UBC Theses and Dissertations

UBC Theses Logo

UBC Theses and Dissertations

Ventral hippocampal lesion volume does not predict working memory deficits in the neonatal ventral hippocampal… Badiudeen, Mohamed Thariq 2015

Warning
You are currently on our download blacklist and unable to view media. You will be unbanned within an hour.
To un-ban yourself please visit the following link and solve the reCAPTCHA, we will then redirect you back here.

Item Metadata

Download

Media
24-ubc_2015_may_badiudeen_mohamed.pdf [ 4MB ]
Metadata
JSON: 24-1.0167163.json
JSON-LD: 24-1.0167163-ld.json
RDF/XML (Pretty): 24-1.0167163-rdf.xml
RDF/JSON: 24-1.0167163-rdf.json
Turtle: 24-1.0167163-turtle.txt
N-Triples: 24-1.0167163-rdf-ntriples.txt
Original Record: 24-1.0167163-source.json
Full Text
24-1.0167163-fulltext.txt
Citation
24-1.0167163.ris

Full Text

 VENTRAL HIPPOCAMPAL LESION VOLUME DOES NOT PREDICT WORKING MEMORY DEFICITS IN THE NEONATAL VENTRAL HIPPOCAMPAL LESION MODEL OF SCHIZOPHRENIA   by  Mohamed Thariq Badiudeen  B.Sc., The University of British Columbia, 2012     A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE  REQUIREMENTS FOR THE DEGREE OF   MASTER OF SCIENCE   in   The Faculty of Graduate and Postdoctoral Studies   (Neuroscience)    THE UNIVERSITY OF BRITISH COLUMBIA (Vancouver)   April 2015   © Mohamed Thariq Badiudeen, 2015      ii Abstract The neonatal ventral hippocampal lesion (NVHL) is the most well-characterized neurodevelopmental animal model of schizophrenia.  NVHL animals are known to display marked deficits in cognitive flexibility and working memory (WM), which are largely reminiscent of cognitive deficits seen in human patients.  Though WM deficits are a well-characterized feature of the NVHL model, our study was the first to use magnetic resonance imaging (MRI), on live rats, to determine the relationship between lesion extent and the working memory deficit in a variable delayed non-match to sample (vDNMS) task.  Similar to the existing literature, NVHL animals showed a significant deficit in performance when compared to sham operated animals.  Interestingly, however, the magnitude of deficit in WM performance in NVHL animals was stable, regardless of delay length.  We suggest that this delay-independent WM deficit reflects inefficiency during the encoding stage of WM processes in NVHL animals.  Additionally, we found no evidence of a relationship between ventral hippocampal (VH) lesion volume and the magnitude of WM deficit, suggesting that there may be a threshold level of VH damage, beyond which no further WM impairment is produced.           iii Preface The experiments presented in this dissertation were designed together by my supervisor, Dr. Jeremy Seamans, my colleague, Dr. James Hyman, and myself.  I conducted all aspects of the experiment, such as animal surgeries and behavioural testing, and performed all data analyses, under the guidance of Drs. Seamans and Hyman.  All experiments described here were conducted in accordance with the Canadian Council of Animal Care, and with the approval of the Animal Care Committee at the University of British Columbia.  The animal protocol numbers, under which all experiments were conducted, was A10-0055 and A14-0084.                iv Table of contents Abstract(...............................................................................................................................................(ii!Preface(...............................................................................................................................................(iii!Table(of(contents(............................................................................................................................(iv!List(of(figures(....................................................................................................................................(vi!List(of(abbreviations(.....................................................................................................................(vii!Acknowledgements(.....................................................................................................................(viii!Dedication(.........................................................................................................................................(ix!Chapter(1:(General(introduction(................................................................................................(1!1.1! Cognitive deficits in schizophrenia(.................................................................................................(3!1.1.1 General overview of cognitive deficits!.....................................................................................................!3!1.1.2 Developmental course of cognitive deficits in patients with schizophrenia!................................!4!1.1.3 Presentation of a working memory impairment in schizophrenia patients!...................................!6!1.2 Evidence of prefrontal cortex dysfunction in schizophrenia(........................................................(8!1.2.1 Neuroanatomical characteristics and post-mortem findings in prefrontal areas of schizophrenia patients!.............................................................................................................................................!10!1.3 Evidence of a dysfunctional hippocampus in schizophrenia(.....................................................(11!1.3.1 Contributions of aberrant hippocampal activity to cognitive dysfunction in schizophrenia!11!1.3.2 Neuroanatomical characteristics and post-mortem findings in hippocampi of schizophrenia patients!.........................................................................................................................................................................!12!1.4 NVHL model(........................................................................................................................................(15!1.4.1 Producing the NVHL model of schizophrenia!....................................................................................!16!1.4.2 Behavioural features of the NVHL model of schizophrenia!..........................................................!17!1.4.3 Neurobiological features of the NVHL syndrome!.............................................................................!20!1.4.4 NVHL as the optimal model of cognitive symptoms in schizophrenia!......................................!21!1.5 Aims of the thesis and use of MRI(..................................................................................................(21!Chapter(2:(Methods(and(materials(...........................................................................................(23!2.1 Subjects(.................................................................................................................................................(23!2.2 Surgeries(...............................................................................................................................................(23!2.3 Apparatus(.............................................................................................................................................(24!2.4 Behavioural tasks(................................................................................................................................(25!2.4.1 Pre-exposure and pre-training on T-maze!.............................................................................................!25!2.4.2 vDNMS testing!..............................................................................................................................................!26!2.5 In-vivo MRI(..........................................................................................................................................(27!2.6 Lesion verification and quantitative assessment(..........................................................................(28!2.7 Post-mortem histology and lesion assessment(..............................................................................(28!2.8 Behavioral analysis(.............................................................................................................................(30!Chapter(3:(Results(.........................................................................................................................(31!3.1 Histology and MRI(.............................................................................................................................(31!3.2 Working memory performance(.......................................................................................................(32!3.3 Relationship between working memory performance and lesion volume(.............................(33!Chapter(4:(Discussion(...................................................................................................................(35! v 4.1 Discrepant findings in the NVHL literature(.................................................................................(35!4.2 Absence of a relationship between lesion volume and performance deficit(...........................(39!4.3 Is delay-independent WM a feature of PFC damage?(................................................................(44!4.4 From specific regions to pathways(..................................................................................................(45!4.5 The underlying nature of the WM deficit in the NVHL model and schizophrenia(.............(47!4.6 Conclusion(............................................................................................................................................(49!Figures(...............................................................................................................................................(50!Bibliography(....................................................................................................................................(71!                             vi List of figures Figure(1.((Illustration(of(TPmaze(configuration.(..................................................................(50!Figure(2.((Illustration(of(disadvantages(in(using(histology(for(lesion(volume(calculations.(.....................................................................................................................................(51!Figure(4aPn.(3D(models(of(NVHL(lesion(shapes(and(respective(performance.(..........(53!Figure(5.((Comparison(of(sham(and(NVHL(animals(on(days(preceding(criterion(performance(on(the(1s(DNMS(task(...........................................................................................(67!Figure(6.(Daily(performance(of(all(animals(in(the(vDNMS(task.(.....................................(68!Figure(7.(Relationship(between(lesion(volume(and(vDMNS(performance.(................(69!Figure(8.((Relationship(between(lesion(volume(and(days(to(reach(criterion(performance(on(the(10s(DNMS(task.(.......................................................................................(70!                                vii List of abbreviations  AH aCSF           BDNF DLPFC DMPFC GAD 67 IBO LFC mPFC MRI NAA NVHL PD PFC RARE rCBF vDB vDNMS VH WCST WM   Anterior hippocampus Artificial cerebrospinal fluid Brain-derived neurotrophic factor Dorsolateral prefrontal cortex Dorsomedial prefrontal cortex Glutamic acid decarboxylase 67 Ibotenic acid Lateral frontal cortex Medial prefrontal cortex Magnetic resonance imaging N-Acetylaspartate Neonatal ventral hippocampal lesion Postnatal day Prefrontal cortex Rapid acquisition with rapid enhancement Regional cerebral blood flow Vertical limb of the diagonal band Variable delayed non-match to sample Ventral hippocampus Wisconsin card-sorting task Working memory   viii Acknowledgements  I would like to offer my sincere thanks and gratitude to my primary supervisor, Dr. Jeremy Seamans, for his guidance, patience, and support.  In working with Jeremy I have been given the opportunity to further pursue my passion for science and have gained invaluable skills as a lifelong learner.  Additionally, I would like to thank my committee members, Drs. William Honer, Anthony Phillips, and Nicholas Swindale, for their thoughtful insight, and constructive criticism in helping to shape my project and review this dissertation.  I am also compelled to thank Dr. James Hyman, who provided tireless motivation and mentorship to me.  Without James’ help, I surely would not have been equipped with skills and knowledge to complete my research.   I would also like to thank Dr. Natalia Gorelova and Barak Caracheo, who both challenged my current way of thinking as a scientist and supported me throughout this entire process. As well, I give my thanks to Sophia Le for her tireless assistance with histology and animal handling; Jamie Grewal for all of his technical assistance; and Adrian Lindsay, Nathan Powell, and Sarah MacDonald for their willingness and ability to offer their help on short notice.  Lastly, I give my most sincere gratitude and respect to my parents, who have always provided me with unconditional support and love.  I thank my mother, Razeena Badiudeen, for instilling in me a strong work ethic and sense of responsibility, and my father, Fazal Badiudeen, for granting me strength and confidence in my ability to succeed in everything I put my mind to.                       ix Dedication For my mother and father.  May you have the strength to stay awake as you read this dissertation in its entirety.                                          1 Chapter 1: General introduction Characterized by significant disturbances of mental functions and subtle brain abnormalities, schizophrenia is a complex psychiatric disorder that affects roughly 1% of the global population (Tseng, Chambers, and Lipska, 2009).  Despite relatively low incidence rates of schizophrenia (median value 15.2 per 100,000 persons per year; McGrath et al., 2004), the disorder is a major contributor to the global burden of disease (Murray and Lopez, 1996).  Psychosis is typically the most salient clinical feature of schizophrenia, however, deficits in such cognitive processes as working memory, sustained attention, and cognitive flexibility are thought to be the core features of schizophrenia (Elvevag & Goldberg, 2000).  These cognitive deficits are known to manifest years before the onset of psychosis, to persist throughout the course of the illness, and are considered to be the best predictors of long-term functional outcome in patients (Gold, 2004).  Yet, despite the clinical significance of cognitive symptoms in schizophrenia, less research has been conducted on this cluster of symptoms when compared to the negative and positive symptoms.  However, the prefrontal cortex (PFC) and hippocampus are two brain regions that have been consistently implicated in contributing to symptom severity in schizophrenia patients.  Evidence of compromised PFC function in schizophrenia, includes findings from studies of cognitive and neuropsychological function (Barch and Carter, 1998; Gold et al., 1997; Goldberg et al., 1987, 1988; Goldberg and Weinberger, 1988; Keefe et al., 1995; Mahurin et al., 1998; Park and Holzman 1992; Stone et al., 1998; Weickert et al., 2000; Wexler et al., 1998), neuroimaging (Andreasen et al., 1996, 1997; Berman et al., 1992; Callicott et al., 1998, 2000; Carter et al., 1998; Catafu et al., 1994; Curtis et al., 1998; Ingvar and Franzen, 1974; Kawasaki et al., 1993; Manoach et al., 1999, 2000; Stevens et al., 1998;  2 Volz et al., 1997; Weinberger et al., 1986, 1988, 1992), eye movements (Cegalis and Sweeney 1979; Holzman et al., 1974; Jacobsen et al., 1996; Lieberman et al., 1992; Litman et al., 1997; Shagass et al., 1974), and electrophysiology (Abrams and Taylor, 1979; Guenther et al., 1988; Hoffmann et al., 1996; Karson et al., 1987; Tauscher et al., 1998).  Indeed, it is widely held that compromised PFC neural systems may provide some explanation of the salient prefrontal-dependent cognitive symptoms, such as working memory (WM) deficits, displayed by those with schizophrenia.   As with the PFC, there is a growing body of literature implicating the hippocampus in the pathophysiology of schizophrenia.  The most significant evidence comes from MRI studies, which show a significant reduction in hippocampal volume of schizophrenia patients when compared to healthy controls (Lawrie and Abukmeil, 1998; Wright et al., 2000; Davatzikos et al., 2005; Narr et al., 2004; Shenton et al., 2001).  Specifically, the anterior hippocampus of schizophrenia patients has shown pronounced differences in volume and shape, with such differences seen less frequently in the posterior hippocampus (Csernansky et al., 2002; Narr et al., 2002; Ho and Magnotta, 2010).  Interestingly, reduced hippocampal volumes have also been observed in prodromal and first episode patients (Bogerts et al., 1990; Lawrie et al., 1999; Joyal et al., 2002; Pantelis et al., 2003), which suggests that hippocampal involvement in schizophrenia is not secondary to the illness or its treatment, but may be developmentally linked to schizophrenia pathogenesis. Despite such a well-characterized knowledge of the neuroanatomical and physiological traits associated with schizophrenia, little is known about the mechanisms underlying the pathophysiology of the disorder.  Therefore, animal models of disease are critically important for investigating the mechanisms underlying human diseases and for the  3 design of new therapies.  Until the early 1990’s, animal models of schizophrenia were primarily pharmacological constructs and typically involved direct manipulation of glutamate or dopamine neurotransmitter systems (Tseng, Chambers, and Lipska, 2009).  Unfortunately, these early models overlooked key features of schizophrenia, such as the developmental pathogenesis, the cognitive symptoms, and potential anatomical features—a major heuristic limitation (Tseng, Chambers, and Lipska, 2009).  However, a relatively recent model known as the neonatal ventral hippocampal lesion (NVHL) model of schizophrenia has proven capable of capturing many important aspects of the disorder that may not be adequately addressed by pharmacological and even genetic models. Below I will provide an overview of the literature concerning the cognitive symptoms of schizophrenia.  Next, both the PFC and hippocampus will be discussed in terms of their involvement in schizophrenia, particularly the role that each region is thought to play in contributing to the severity of cognitive symptoms of the disorder.  Finally, the NVHL model will be discussed in detail.  This chapter will conclude with an outline of the overall objectives of this thesis.  1.1 Cognitive deficits in schizophrenia 1.1.1 General overview of cognitive deficits Schizophrenia is a complex brain disorder characterized by clinical heterogeneity of symptom presentation including deficits in cognitive abilities, such as WM, sustained attention, and other executive functions (Lee and Park, 2005).    Although cognitive dysfunction in schizophrenia may sometimes be overlooked in light of the more salient positive and negative symptoms, cognitive dysfunction is now being seen as a core feature of  4 the disease and major predictor of functional outcome (Green et al., 2000).  Indeed, there exists a large volume of empirical evidence in support of the notion of cognitive dysfunction as a core feature of schizophrenia.  For example, several studies have shown that patients will present symptoms indicative of cognitive deficits, such as problems with working memory, sustained attention and declining IQ, well-before the clinical onset of the illness (e.g., Aylward, Walker, and Bettes, 1984; Kremen et al., 1998).  Similarly, impaired cognitive functioning is also evident in the non-affected biological relatives of patients, although to a slightly milder degree (Cannon et al., 1994; Goldberg et al., 1993).  Finally, despite changes in the magnitude of cognitive dysfunction with changes in clinical state, cognitive dysfunction is still known to be largely persistent even during times of positive and negative symptom remission (Gold and Harvey, 1993).  Thus deficits in cognitive performance represent a stable, central core feature of schizophrenia. 1.1.2 Developmental course of cognitive deficits in patients with schizophrenia   Cognitive impairments are commonly reported in first-episode patients with schizophrenia (Bilder et al., 1992; Hoff et al., 1992; Censits et al., 1997) and these impairments persist into the chromic stages of the disease (Goldberg and Seidman, 1991; Heaton et al., 1994).  In fact, cognitive impairment often significantly predates the onset of clinical diagnosis.  For example, children who later went on to develop schizophrenia were found to have on average lower scores on scholastic tests than comparison children at ages 8, 11, and 15 years old (Jones et al., 1994).  Further, the cognitive impairment noted in these children appeared to worsen with time, as the most robust findings were seen when children were measured at 15 years of age (Jones et al., 1994).  Similarly, Ambelas (1992) discovered  5 that children who later developed schizophrenia had lower IQ scores and impaired speech, language, and reading performance, when compared to similarly aged children who did not develop schizophrenia.  Interestingly, in a large scale study of healthy male adolescents, a linear relationship was found between cognitive functioning and later risk of developing schizophrenia (David et al., 1997; Davidson et al., 1999).  Thus, premorbid cognitive impairment is a well-documented feature of schizophrenia (Fuller et al., 2002).  The early emergence of cognitive impairment and its robust relationship to the risk of later developing schizophrenia implicates the involvement of aberrant neurodevelopmental processes, in what is known as the neurodevelopmental theory of schizophrenia.  This theory suggests that both genetic and environmental factors confer vulnerability to developing schizophrenia, and occur well before the clinical manifestation of schizophrenia. These factors may alter the normal course of neural development and produce changes in specific types of neurons and circuits (Murray and Lewis, 1987, Weinberger, 1987).  According to this theory, abnormal genetic and/or epigenetic factors work synergistically to disrupt processes of early brain development, such as cellular proliferation, differentiation, migration, and synaptogenesis (Murray and Lewis, 1987; Weinberger, 1987; Ho, Andreasen, Nopoulos, et al., 2003).  Processes occurring later in brain development, such as synaptic pruning and apoptosis, as well as other neuropathological events, such as stress, are then thought to interact with the abnormally developed brain to produce the characteristic attributes of schizophrenia in late adolescence to early adulthood (Ho, Andreasen, Nopoulos, et al., 2003). Imaging studies have implicated developmental abnormalities in regions essential to cognitive functioning, such as the hippocampus (Narr et al., 2002; Narr et al., 2004) and PFC (Catafau et al., 1994; Weinberger and Lipska, 1995).  Abnormalities in these regions have  6 been shown to manifest in a variety of different ways, such as through altered cortical thickness (Kuperberg et al., 2003), hippocampal volume and shape (Johnson et al., 2013), and cerebral asymmetry (Crow et al., 1989).  Volumetric differences have been noted in both, drug-naïve and first-episode patients (Gur et al., 1999; Szeszko et al., 2003), with some patients even showing these deficits before the onset of psychosis, in the prodromal stage of the illness (Pantelis et al., 2003).  Additionally, there is substantial evidence (e.g., Bogarts et al., 1985; Benes, Sorensen, and Bird, 1991; Arnold et al., 1995) implicating the involvement of microscopic, histological changes in the brains of schizophrenia patients that further implicate aberrant neurodevelopmental processes as a major contributor to the onset of cognitive symptoms.  One of the most notable histological findings in schizophrenia is that of aberrant neuronal clustering or migration in the lateral temporal lobe and parahippocampal white matter (Akbarian et al., 1993), entorhinal cortex (Arnold et al., 1991; Harrison and Weinberger, 2005), and prefrontal white matter (Akbarian et al., 1996).  Such aberrations implicate an early neurodevelopmental event affecting the proper migration, connectivity, and ultimate survival of developing neurons (Roberts, 1990; Harrison, 1997).  These developmental neuropathological changes may be responsible for the cognitive symptoms of schizophrenia. 1.1.3 Presentation of a working memory impairment in schizophrenia patients Cognitive symptoms, notably WM deficits, are thought to be core feature of schizophrenia (Goldman-Rakic, 1996).  Broadly defined, WM is a capacity-limited system, which allows an individual to hold task-relevant information while he/she works towards  7 solving a problem (Baddeley, 1992).  Following the cessation of sensory input, information is transiently represented in WM and used to plan or decide on a course of action towards completing a goal (Goldman-Rakic, 1994; Silver et al., 2003).  Baddeley (1986) initially suggested that WM consists of a central executive and two slave systems: a visuospatial scratch pad and a phonological loop capable of retaining modality-specific information over short periods of time.   WM is fundamental to numerous cognitive and executive processes and dysfunctional WM in schizophrenia may underlie the cognitive organization deficits, impaired goal-oriented behavior and failure of self-monitoring (Silver et al., 2003).  If WM deficits are a salient and central feature of schizophrenia, then identifying the factors that impair WM function becomes a critical step in uncovering the underlying disease process. However, gaining a clear and decisive understanding of WM deficits in schizophrenia patients is hindered by the lack of homogeneity in patient samples and working memory testing procedures (Forbes et al., 2009).  However, despite such heterogeneity, meta-analyses by Forbes et al. (2009) and Lee and Park (2005) found consistent deficits in schizophrenia patients across phonological, central executive, and visuospatial domains of WM across diverse methodologies and approaches. In addition, the study of Lee and Park (2005) also noted that the WM deficit in patients was typically delay-independent.  Specifically, it was found that increasing the duration of the delay period in a WM task beyond one second did not lead to any more robust WM deficits in schizophrenia patients compared to controls (Lee and Park, 2005).  Such reliable delay-independent performance deficits seem to argue against the idea that WM representations are inherently unstable or prone to decay in patients. Rather, this pattern of performance deficit may implicate a more basic problem in the encoding stage of the WM task, such as difficulties  8 attending to task-relevant information (Adler et al., 1998)—an idea that will be returned to in Chapter 4 of the current dissertation.    1.2 Evidence of prefrontal cortex dysfunction in schizophrenia PFC dysfunction remains a core component of current theories of the pathophysiology of schizophrenia (Lewis, Hashimoto, and Volk, 2005; Harrison and Weinberger, 2005).  The PFC plays an essential role in flexible decision making (Ragozinno et al., 1999), conflict resolution, specific memory processes, and executive functions—capacities that are compromised in schizophrenia (Rushworth and Behrens, 2008).  Indeed, certain cognitive symptoms of schizophrenia, such as working memory deficits, reflect alterations in executive control processes that rely on a properly functioning dorsolateral prefrontal cortex (DLPFC; Miller and Cohen, 2001).  The most significant evidence that individuals with schizophrenia have abnormal DLPFC activity comes from experimental paradigms that incorporate neuroimaging techniques with neuropsychological testing.  For example, healthy control subjects performing the Wisconsin Card Sorting Task (WCST)—a task requiring effective problem solving skills, abstract reasoning, and working memory (Weinberger and Lipska, 1995)—show an increase in prefrontal activation as task difficulty increases (Weinberger, Berman, and Zec, 1986).  Conversely, schizophrenia patients performing the same task show an inverse relationship between task demands and activation of the frontal cortex (i.e., hypofrontality; Weiberger, Berman, and Zec, 1986).  In fact, the severity of the deficit in DLPFC activation, but not activation of any other cortical region(s), predicts the severity of cognitive disorganization symptoms in schizophrenia patients (Silver et al., 2003).    9 Studies of regional cerebral blood flow (rCBF) in monozygotic twins discordant for schizophrenia show an attenuated prefrontal blood flow index for schizophrenic twins compared to non-schizophrenic twins (Berman, Torrey, and Weinberger, 1992).  Specifically the ratio of prefrontal rCBF to non-frontal rCBF was relatively more reduced in the schizophrenic versus non-schizophrenic twin.  This approach has been applied to broader cohorts of patients and reduced DLPFC rCBF has been observed in acute, chronic, medicated (Weinberger and Lipska, 1995), and neuroleptic-naïve patients (Catafau et al., 1994).  These findings suggest that a sizeable group of schizophrenia patients display reduced frontal lobe activation across a variety of cognitive tasks and this phenomenon has become known as hypofrontality. However, hypofrontality is not always observed in patients and several functional imaging studies have found the opposite or hyperfrontal cortical activation in response to task demands (Manoach et al., 1999; Callicott et al., 2000; Callicott et al., 2003).  For example, Manoach et al. (1999) found that relative to control subjects, schizophrenia patients displayed hyperfrontal left DLPFC activation in response to low WM demands, but hypofrontal left DLPFC activation at high WM demands.  Thus patients may be able to compensate by increasing DLPFC activation up to a critical point, and beyond that, their WM capacity is tapped (Manoach et al., 1999).  This is consistent with the idea that prefrontal pathology in patients confers an abnormal or ‘inefficient’ neural strategy for dealing with WM information (Callicott et al., 2003).    10 1.2.1 Neuroanatomical characteristics and post-mortem findings in prefrontal areas of schizophrenia patients Anatomical and epidemiological studies in schizophrenia led to the hypothesis that disruption of normal, orderly brain development may be a major contributor to the etiology of the disorder (Bunney and Bunney, 2000).  In large part, this hypothesis was motivated by findings that, in schizophrenia, abnormal patterns of neuronal migration may affect the development of the cerebral cortex, thus providing a mechanism by which cortical connectivity and associative functions, like cognitive processes dependent on the communication between the PFC and hippocampus, could be disturbed (Jones, 1997; Bunney and Bunney, 2000).  That is, cognitive disturbances in schizophrenia are thought to be, in part, a result of a developmental disconnection of fronto-temporal cortices (Weinberger and Lipska, 2005).  For example, in the cingulate cortex of schizophrenia patients a laminar shift in neuronal density (Benes et al., 1991) appears to implicate improper or failed migration of developing neurons into their appropriate cortical target sites (Weinberger and Lipska, 1995).  Indeed, this impaired ability of prefrontal neurons to reach their appropriate target sites likely also means that these neurons are unable to make their appropriate, designated connections with other neurons (Rakic, 1988).  This would affect both afferent and efferent projections of the PFC to key regions associated with higher order cognitive processes (Schubert, Martens, and Kolk, 2014).  As a result, the ability of functionally and anatomically distinct systems in the brain to communicate with one another, coordinate activity, and process information is disrupted, likely manifesting in inefficient or noisy processing abilities and impaired cognitive performance (Weinberger and Lipska, 1995).     11 Studies of post-mortem tissue in schizophrenia show that patients’ brains differ from those of control subjects with regards to neuronal density, patterns of neuronal cell settling, and in gene expression of neurotransmitter-related molecules especially in the PFC (Lewis, Hashimoto, and Volk, 2005). In particular, mRNA for glutamic acid decarboxylase 67 (GAD67), a GABA-synthesizing enzyme, are significantly reduced in the PFC of schizophrenic patients (Akbarian et al., 1995; Volk et al., 2000; Guidotti et al., 2000).  These differences may ultimately contribute to the cognitive deficits seen in the disorder.  For example, GABAergic DLPFC neurons may be necessary for normal WM performance by either tuning or synchronizing WM related activity (Lewis, Hashimoto, and Volk, 2005; Constantinidis, Williams, and Goldman-Rakic 2002).    1.3 Evidence of a dysfunctional hippocampus in schizophrenia  1.3.1 Contributions of aberrant hippocampal activity to cognitive dysfunction in schizophrenia The hippocampal formation has also been implicated in the pathophysiology of schizophrenia.  Indeed, many of the memory impairments noted in patients with schizophrenia are thought to be a direct consequence of dysfunction in hippocampal circuits (Boyer et al., 2007).  Consistent with this view, the memory deficits in patients are often in the realm of contextual or spatial information (see: Cohen and Servan-Schreiber, 1992; Rizzo et al., 1996; Bazin et al., 2000).  Moreover, the context memory hypothesis of schizophrenia proposed by Rizzo et al., (1996), suggests that patients struggle in encoding or binding together contextual information to form an intact memory representation.   For example, patients with schizophrenia show poor performance on tasks requiring them to remember both a word  12 previously presented on a screen as well as its spatial location (Rizzo et al., 1996).  Similarly, Burglen et al., (2004) tested contextual binding in schizophrenia patients and found them particularly deficit in the combination condition, relative to the recognition of either the target or its location alone.   The hippocampus may also contribute to WM retrieval and Heckers et al. (1998) proposed that hippocampal dysfunction could contribute to errors during the retrieval stage of a WM task in patients with schizophrenia. Heckers et al. (1998) found hippocampal recruitment in patients was significantly reduced during a task that required high-level semantic encoding followed by later conscious recollection.  Conversely, at baseline and low task demands, patients displayed hippocampal hyperactivity compared to control subjects.  Additionally, when task demand was high, patients showed increased regional cerebral blood flow (rCBF) to several prefrontal regions, which was thought to reflect an increase in cognitive effort during the task. This increased frontal activity was interpreted as an attempt to compensate for failing to efficiently recruit the hippocampus.  These findings are in line with the studies cited above (e.g., Manoach et al., 1999; Callicott et al., 2000; Callicott et al., 2003) in which patients displayed hyperfrontal activation in response to WM task demands.    1.3.2 Neuroanatomical characteristics and post-mortem findings in hippocampi of schizophrenia patients   Evidence from histopathological studies indicates anatomical abnormalities in the hippocampi of schizophrenia patients, such as a reduction in hippocampal area or volume (see: Bogarts, Meertz, and Schonfeldt-Bausch, 1985; Jeste and Lohr, 1989; Suddath et al., 1990; Weiss et al., 2005).  Further, evidence of generalized hippocampal atrophy, decreased neuronal density (Falkai and Bogerts, 1986) and size (Arnold et al., 1995), and pyramidal cell  13 disorganization (Kovelman and Scheibel, 1984; Conrad et al., 1991) have also been shown to be present in the brains of schizophrenia patients.  However, volume reductions and shape deformations in the hippocampal formation are one of the most frequently stated findings in post-mortem (Bogerts et al., 1990), anatomical imaging (Narr et al., 2004; Davatzikos et al., 2005), and twin (Goldberg et al., 1994) studies of schizophrenia patients.  A meta-analysis by Adriano, Caltagirone, and Spalletta (2012) of 44 structural MRI studies showed significantly reduced bilateral hippocampal volume in schizophrenia patients.  Interestingly, these hippocampal volume abnormalities often precede the clinical onset of schizophrenia (Lawrie et al., 1999).  Studies of hippocampal shape analysis have shown that deformations are most significant in the anterior hippocampus of patients with schizophrenia (Csernansky et al., 2002; Narr et al., 2004; Ho and Magnotta, 2010). This region projects to the PFC and is thought to be involved in associative memory (Strange et al., 1999; Bannerman et al., 2004).  Interestingly, such anatomical changes have also been shown to correlate with specific cognitive deficits and illness severity (Boos et al., 2007; Hasan et al., 2011; Adriano, Caltagirone, and Spalletta, 2012).  For example, Hasan et al. (2011) described a significant correlation between left hippocampal volume and verbal memory performance in first-episode schizophrenia patients, but failed to show any correlation between hippocampal volume and performance on tests of cognitive flexibility or working memory.   Contributing to the reduction of hippocampal volume are findings of ventricular enlargement in patients with schizophrenia.  Johnstone et al. (1976) showed institutionalized schizophrenia patients have significantly enlarged ventricular size when compared to healthy controls.  This study also noted a significant relationship between ventricular size and impairment on cognitive testing.  Similarly, Bilder et al. (1995) found an inverse relationship  14 between anterior hippocampal volume and performance on tasks of executive functions in patients with first-episode schizophrenia.  However, it should be noted that the relationship between hippocampal volume and cognitive impairment is not entirely clear, as there is also evidence of a lack of a relationship between hippocampal abnormalities and symptom severity or illness duration.  For example, Csernansky et al. (2002) found that, despite the presence of abnormalities in areas of the hippocampus that project to the PFC, the magnitude of these abnormalities in hippocampal shape or asymmetry in schizophrenia patients was unrelated to either symptom severity or illness duration. There is also a body of evidence suggesting that abnormalities in the cytoarchitecture of hippocampal cells exists in patients with schizophrenia (Arnold et al., 1997).  Altered cytoarchitecture of hippocampal cells may adversely affect the ability of neurons to entrain task-related field potential oscillations—potentially influencing the overall functionality of the hippocampus, including its ability to efficiently communicate with other regions (Boyer et al., 2007).  A study by Benes et al. (1991) showed schizophrenia patients have significantly smaller pyramidal neurons in CA1-CA4.  Similarly, Zaidel et al. (1997) reported reduced neuronal size in the left CA1, left CA2, and right CA3 subfields of patients with schizophrenia.  Further evidence of altered hippocampal cytoarchitecture comes from Nesvaderani, Matsumoto, and Sivagnanasunduram (2009), who found evidence of aberrant protein expression profiles in the anterior hippocampus of patients.  This evidence of altered cytoarchitecture in the anterior hippocampus is consistent with the hypothesis that aberrant wiring within the anterior hippocampus and its efferent projections, particularly to the PFC, may underlie the cognitive deficits in schizophrenia (Goldman and Mitchell, 2004; Harrison, 2004).  15 Given the importance of potentially aberrant wiring within the human anterior hippocampus to its efferent projection areas like the PFC in schizophrenia, it is necessary to gain a better understanding of the impact of these wiring changes on cognitive abilities in schizophrenia patients.  To do so, one must turn to animal models, which capture the anatomical and functional connectivity between the anterior hippocampus and the PFC in humans.  Indeed, such a pathway, referred to as the H-PFC pathway, exists in the rat (Godsil et al., 2013).  The H-PFC pathway is composed of neurons projecting from the subiculum and CA1 of the VH directly to the PFC (Jay, Glowinsky, and Thierry, 1989; Godsil et al., 2013) and thus, effectively captures the connectivity seen between the human anterior hippocampus—the structural analog of the rat VH (Bannerman et al., 2004)—and the PFC. Given the direct connectivity between the hippocampus and PFC through the H-PFC pathway, it is unsurprising to learn that this network supports both up and down regulation of synaptic connectivity and is also recruited during WM performance (Jay et al., 2004).  Thus, the study of this pathway may help advance the current understanding of WM deficits in psychiatric disorder in schizophrenia.  Indeed, such a model exists.  1.4 NVHL model   Until roughly 20 years ago, animal models of schizophrenia were largely pharmacologically based and focused on direct manipulation of dopamine and glutamate neurotransmitter systems (Tseng, Chambers, and Lipska, 2009).  These approaches were consistent with a large body of evidence implicating dysfunction of the dopaminergic system with schizophrenia (Chambers et al., 1996; Lipska and Weinberger, 2000; Chambers, Krystal and Self, 2001; Harrison and Weinberger, 2005; Tseng, Chambers, and Lipska, 2009). Even  16 though dopamine-based models have great predictive validity given the efficacy of dopamine antagonists as anti-psychotics (McKinney and Moran, 1981; Costall and Naylor, 1995; Cools et al., 1990), these drugs tend to be ineffective in attenuating cognitive symptoms of schizophrenia (Tseng, Chambers, and Lipska, 2009).  Lesion models of schizophrenia, however, are often better at encompassing aspects of the neurobiological characteristics of the disease as well as the cognitive symptoms.  Specifically, the NVHL model, created by Lipska and Weinberger (1993), involves a developmentally-timed excitotoxic lesion to the VH, which results in the emergence of several behavioural, neuro-anatomical and –chemical alterations in early adulthood.  As such, the NVHL model is the most capable heuristic model of the cognitive deficits in schizophrenia. With more than 100 empirical studies using the NVHL model to-date, it is the also the most thoroughly characterized neurodevelopmental model of the disorder (Tseng, Chambers, & Lipska, 2009).  In fact, its ability to capture the developmentally delayed onset of symptoms in a manner similar to the onset of symptoms in human schizophrenia patients is one of its notable advantages (Marcotte, Pearson, and Srivastava, 2001). 1.4.1 Producing the NVHL model of schizophrenia  Ventral hippocampal lesions are made in postnatal day 7 (PD7) rat pups using the NMDA receptor agonist, ibotenic acid (α-amino-3-hydroxy-5-isoxazoleacetic acid; IBO).  PD7 was chosen as a developmental time point as it is analogous to the second trimester of human fetal brain development—a sensitive period of hippocampal network formation (Chambers and Lipska, 2011).  IBO, when delivered in concentrated doses to specific brain areas, induces excitotoxic cell death.  However, one advantage of IBO is that it spares axons of passage (Chambers and Lipska, 2011).  Thus, IBO infusion to the VH of PD7 rat pups kills  17 only projection neurons and hence the efferent projections of the VH to other cortical regions, most notably, the PFC.   VH lesions in PD7 rat pups compromise the architectural integrity of the mPFC (Carr and Sesack, 1996), which is thought to play a role in mediating the post-pubertal emergence of the behavioural symptoms in NVHL animals (Lipska, Al-Amin, & Weinberger, 1998).  This is congruent with the hypothesis that neurodevelopmental abnormalities that disrupt the normal development of the human anterior hippocampus—which is analogous to the VH in rats—may underlie the cognitive deficits that rely on fronto-temporal communication (Bilder et al., 1995).  1.4.2 Behavioural features of the NVHL model of schizophrenia As previously mentioned, the rat VH corresponds to the human anterior hippocampus, which has consistently been associated with cognitive symptoms in schizophrenia patients (Csernansky et al., 2002; Narr et al., 2002; Tseng, Chambers, & Lipska, 2009; Ho and Magnotta, 2010).  Unlike other animal models of schizophrenia, the developmentally timed VH lesion produces analogous cognitive symptoms to those seen in human patients with schizophrenia. The relevance of the model to positive and negative symptoms of schizophrenia is a matter of debate but will be discussed briefly below. Dopamine (DA) dysfunction is thought to underlie at least some of the positive symptoms of schizophrenia largely by virtue of the fact that the DA releaser amphetamine can reproduce psychotic-like symptoms in normal adults and because all effective antipsychotic agents block D2 receptors (Seeman, 1987). NVHL animals may also have altered DA system function given their hypersensitivity to amphetamine or apomorphine challenge in the post-adolescent period (Lipska, Jaskiw, & Weinberger, 1993; Lipska and Weinberger 1993).   18 NVHL animals also have an enhanced immobility response to neck clamping, when compared to control animals, which is suggested to be a result of aberrant mesolimbic DA transmission (Flores et al., 2005b).  Lipska and Weinberger (1993) also found NVHL animals to be less cataleptic in response to haloperidol injection, when compared to sham lesioned animals.  Aside from the potential parallels to direct changes in the DA system, NVHL animals also exhibit deficits in the expression of pre-pulse (Becker et al., 1994), and latent (Grecksch et al., 1999) inhibition, which are also observed in schizophrenia patients and thought to reflect enhanced behavioural reactivity and reduced ability to ignore irrelevant stimuli, respectively (Tseng, Chambers, and Lipska, 2009).  Evidence of negative-like symptoms in NVHL animals has also been documented.  NVHL animals demonstrate abnormal social behaviours, such as frequent displays of aggression and spend less time in social interactions (Becker et al., 1999; Tseng, Chambers, and Lipska, 2009).  Becker and Grecksch (2000) reasoned that such abnormal social behaviour in NVHL animals may be the result of poor social memory.  Interestingly, the abnormalities in social behaviour do not emerge in a developmentally-dependent manner, as is the case for both the positive- and cognitive-like symptoms in NVHL animals (Tseng, Chambers, and Lipska, 2009).  Rather, in NVHL animals, social behaviour abnormalities are evident both before and after puberty and are largely unresponsive to antipsychotic medications (Sams-Dodd, Lipska, & Weinberger, 1997).  Although the source of these social behavioural abnormalities is uncertain, they are not considered to involve anxiety, as there were no differences between NVHL and sham lesioned animals on performance of an elevated plus maze task (Becker et al., 1999).  19 While there may be parallels to the positive and negative symptoms, the NVHL model is mainly considered to be a model of the cognitive deficits in schizophrenia. As noted above, NVHL animals display cognitive-like symptom traits, such as show poor performance on tasks of spatial learning and working memory.  Specifically, lesioned animals show impaired place learning on the Morris water maze task, despite intact sensorimotor functions and motivation to escape (Lipska et al., 2002; Tseng, Chambers, and Lipska, 2009).  In a delayed non-match to sample task of working memory, Lipska et al., (2002) highlighted a delay-dependent deterioration of performance in NVHL animals, which closely resembled the performance of animals with adult lesions of the PFC. Surgical ablation of the PFC in adult NVHL rats was found to normalize some of the behavioural effects of the initial NVH lesion, such as enhanced responsiveness to novelty and amphetamine administration (Lipska, Al-Amin, & Weinberger 1998).  These findings seem to suggest that a neonatal insult to the ventral hippocampus impairs an animal’s later performance on tasks that are dependent on the integrity of the PFC and communication between the PFC and VH (Lipska et al., 2002).  Importantly, these cognitive-like symptoms in NVHL animals only begin to emerge around the time of puberty and are stable throughout the lifetime of the animal, as seen in patients (Lipska and Weinberger, 2002).   Further, since the PFC is a relatively late-maturing structure with extensive excitatory connectivity with the VH (Van Eden and Uylings, 1985), the previous findings also suggest that a dysfunctional PFC in the NVHL rat may be a downstream driving force in the expression of the behavioural changes that emerge in puberty and adulthood (Lipska, Al-Amin, & Weinberger 1998).    20 1.4.3 Neurobiological features of the NVHL syndrome PFC disturbance in NVHL animals is considered to be a valid model of the cortical deficits seen in human patients with schizophrenia (O’Donnell et al., 2002).  As mentioned above, subsequent lesions of the PFC in adult animals that received a neonatal VH lesion have been shown to restore NVHL-induced behavioural abnormalities.  This suggests that a critical requirement for the expression of the NVHL syndrome is the aberrant development of the PFC and that this abberant development is actually worse than lacking a PFC at all (Tseng, Chambers, & Lipska, 2009).  The critical alterations in the PFC that cause the cognitive deficits are not entirely clear, but include structural changes such as a reduction in spine density and dendritic length of PFC pyramidal neurons (Flores et al., 2005a; Alquicer et al., 2008).  The brains of NVHL animals also have abnormally low cortical expression of glutamate transporter proteins, reduced levels of N-acetylaspartate—considered to be a marker of neuronal integrity (NAA; Lieberman et al., 2001), brain-derived neurotrophic factor (BDNF), and GAD 67; as well as abnormal cortical expression of activity-dependent transcription factors such as, c-fos and Δ-fosB (Lipska et al., 1995; Lee and Kornetsky, 1998; Bertolino et al., 1999; O’Donnell et al., 1999).  Importantly, many of these neuroanatomical alterations have also been reported in human schizophrenia patients (Weinberger and Lipska, 1995; Chambers, Krystal, & Self, 2001; Harrison and Weinberger, 2005). In addition there is a dysfunction in the ability of DA via D2 receptors to modulate fast-spiking interneurons in the PFC of NVHL animals (Gruber et al., 2010; O’Donnell, 2012).  A reduced capacity of pyramidal neurons to activate inhibitory interneurons and/or an alteration in the ability of DA to modulate interneurons, may result in a disinhibited or hyperactive PFC, a decreased neural  21 signal to noise in PFC networks and ultimately deficits in cognitive performance (Winteerer & Weinberger 2004).   1.4.4 NVHL as the optimal model of cognitive symptoms in schizophrenia   By highlighting the neurodevelopmental pathway in the schizophrenia disease process, the NVHL model affords investigation into the complex genetic, developmental, neuronal, and environmental-based foundations of schizophrenia.  The downstream neurobiological effects on the development of the prefrontal and hippocampal formations show that a NVHL lesion can alter gene expression and neural morphology without directly manipulating the genome.  When compared to cross-sectional genetic animal models of schizophrenia, the NVHL model may, therefore, be better equipped to more accurately reproduce the gestalt of schizophrenia disease process (Tseng et al., 2009).   No other animal model of schizophrenia is able to parallel the cognitive deficits in schizophrenia as accurately as the NVHL model.    1.5 Aims of the thesis and use of MRI  A major limitation of lesion studies is the inability of the experimenter to effectively control the size of a lesion.  As a result, animals are often excluded from studies based on qualitative differences in lesion size, with no credible effort made to quantify lesion volume and compare this volume against task performance.  Nowhere is this more true than in the NVHL literature, where animals are routinely excluded from experiments based on a mere qualitative assessment of lesion size, often as being too small.  Not only is this an imprecise practice, but it is also unfounded, as there have been no studies linking the extent of hippocampal damage in NVHL animals with their performance on any behavioural tasks.  Thus, the specific aim of this thesis is to assess the relationship between NVH lesion volume  22 and performance on a variable delayed non-match to sample (vDNMS) task of WM.  Based on work investigating the effects of hippocampal IBO lesions on adult primates (e.g., Murray and Mishkin, 1998), we hypothesized that VH lesion volume would be positively correlated with WM performance in our animals.  We assessed VH lesion volume using MRI in living animals. MRI is preferable to histological processing, because the former circumvents potential artifacts of traditional histological analyses such as tissue shrinkage or damage during tissue preparation. The use of MRI to calculate lesion volume in-vivo is a well-validated technique, and is often used in place of post-mortem histological analysis of lesion volume for these reasons (Miyabe et al., 1996; Takano et al., 1998; Nemanic et al., 2002; Kazemi et al., 2004; Sandner et al., 2010).  Typically the two procedures are in good agreement however and Bertrand et al. (2010) showed that MRI analysis of lesion extent in NVHL animals was robustly correlated with qualitative lesion extent obtained from histological examination.  Further, Malkova et al. (2001) showed that T2-weighted MRI hypersignals were highly correlated with histological analysis of lesion extent (r = 0.95, P < 0.001).  Thus, the use of MRI to calculate lesion volume rather than histology, is a more convenient and efficient alternative and is well validated in the literature.      23 Chapter 2: Methods and materials 2.1 Subjects Pregnant Long-Evans dams were acquired at approximately 14 days of gestation and housed individually in breeding cages.  On PD7, female pups were permanently removed, resulting in litters of 2-10 male pups.  Animals were housed in a facility with a 12 hr light/dark cycle; all training and surgeries took place during the light cycle.  Once they reached the age required for behavioural training (PD50), pups were singly housed and placed on a food-restricted diet.  For the duration of training and testing on our behavioural paradigm, all animals were restricted to 90% of their free-feeding weight.  Feeding took place in the animals’ home cage following their daily training session.  Water was available ad libitum for all animals. All procedures were carried out in accordance with the Canadian Council of Animal Care and the Animal Care Committee at the University of British Columbia.  2.2 Surgeries Male rat pups were randomly assigned to lesion (n = 16) or sham (n = 7) status.  Surgeries were performed on PD7 as described by Lipska et al. (1993).  Briefly, rat pups were anesthetized via hypothermia by placement on wet ice for 15-20 min.  After reaching a surgical plane of anesthesia, pups were immobilized by use of adhesive tape to secure them onto a styroform platform that was fixed to a stereotaxic Kopf instrument (David Kopf Instruments, Tunjunga, CA, USA).  Following immobilization, a single incision was made in the scalp, exposing the underlying skull.  IBO (0.3 µl; Sigma Chemical Co.) was dissolved in  24 artificial cerebrospinal fluid (aCSF; 10 µg/µl), or 0.3 µl of aCSF alone, was injected bilaterally into the ventral hippocampus (AP −3.0 mm, ML ±3.5 mm, VD −5.0 mm, relative to bregma; Chambers and Lipska, 2011) at a rate of 0.133 µl / min.  After the injection was finished, the needle was left in place for 3.5 minutes, to prevent backflow of IBO or aCSF into the needle track, before being withdrawn.  Next, the incision site was closed with veterinary wound closure glue, which was allowed to fully dry while pups were placed under a heating lamp.  Pups were returned to their mothers 30-45 min after recovering from anesthesia, when they were fully mobile and awake.  Pups were weaned at PD24 and housed 2-3 per cage, based on lesion status.     2.3 Apparatus All rats were trained and tested on a T-maze (Fig. 1), consisting of a 48-inch long main stem, with two 22-inch long choice arms that ran perpendicular to the main stem.  Each choice arm was connected to the base of the main stem by a left and right return arm, allowing rats to start a new trial by returning to the base of the stem after making a turn down either the left or right choice arms.  The maze contained five experimenter-controlled doors: two doors (“return doors”), located at the left and right of the base of the maze’s stem, could be closed to prevent re-entry into the return arms.  Two additional doors (“choice doors”), located at the top of the stem could be closed to direct rats into either the left or right choice arm or, alternatively, could both be kept open, allowing rats to freely enter the arm of their choosing.  A fifth door (“stem door”) was located on the stem floor and served to isolate rats to the base of the stem for the beginning of a trial and during delay periods on the vDNMS task (described below).  All maze floors measured 5.5-inches wide and were constructed of solid pine wood; floors  25 were enclosed by 6-inch high walls made of flexible corrugated plastic.  All doors of the maze were constructed of 0.25-inch thick plexiglass.  The entire maze was painted black and was elevated 48-inches off the floor.  Fixed spatial cues (black, pink, or green geometrical designs) were located on three of the surrounding walls of the testing room.  The position of the experimenter in the room was fixed thus, serving as an additional spatial cue.  2.4 Behavioural tasks  2.4.1 Pre-exposure and pre-training on T-maze Training on the T-maze began with 3 days of 15 minute pre-exposure sessions.  During these sessions, rats were placed in the maze with all doors opened, and chocolate cereal loops on the maze floor.  The experimenter was present in the room during pre-exposure sessions in order to allow the animals to habituate to the presence of the experimenter.  Following pre-exposure, animals were trained to make forced-alternations, where they were directed into the left or right choice arm, by means of closing the door to the opposite choice arm, and received a chocolate cereal loop reward at the end of each arm.  Animals were given 5 days of forced-alternation training, with each day’s training consisting of 10-12 alternations.   Upon successful acquisition of the forced-alternation task, animals were trained on a 1 second DNMS task.  In this DNMS task, sessions began by placing animals at the base of the maze’s stem; all surrounding doors were closed, effectively containing the animal.  Next, the experimenter lowered the base door, allowing the animal to travel down the stem.  At the opposing end of the stem, the animal was forced to make either a left or right turn after the  26 experimenter closed either the right or left choice door, respectively (forced run).  Forced runs were not reinforced with chocolate cereal loops.  Once the animals had completed the forced run, they returned to the base of the stem by means of the return arm where, once again, all doors would be closed and the animal was contained (delay period).  After a one-second delay, the base door was lowered and both choice arm doors were opened (choice run).  Animals were only rewarded if they entered the arm opposite to that entered in the previous forced run (non-match to sample).  A different pattern of randomly-chosen forced runs with an equal number of left and right turns (e.g., L-L-R-R…) was used everyday, with the same pattern being used for all animals on any given day.  Animals were tested daily on this 1 sec DMNS training task until they reached criterion performance of at least 80% correct trials over 3 days.  Once criterion had been reached animals were trained on a 10 sec DMNS task until they reached criterion performance, which was defined as less than 10% variance in performance over 5 days, regardless of choice accuracy (Lipska et al., 2002). 2.4.2 vDNMS testing Upon successfully reaching criterion performance on the 10 sec DMNS task, animals were tested on a vDNMS task.  This task was similar to the 1 sec and 10 sec DMNS tasks, with the only difference being that animals were contained in the base of the stem for either 10, 20, or 30 seconds during the delay period.  Each vDNMS testing session consisted of 20 trials, containing an equal number of left and right turns, and a roughly equal number of each delay length.  Again, a different pattern of randomly-chosen forced runs with an equal number of left and right turns, and roughly equal number of each delay length was used everyday, with the same pattern being used for all animals on a given day.  27 2.5 In-vivo MRI  In vivo MRI was used to enable visualization, and volumetric calculations, of lesions in NVHL animals at roughly six months of age.  Both, NVHL and sham animals were imaged.  Rats were first anesthetized using isoflurane inhalation (4 % for induction; 1.5% for maintenance).  Body temperature was maintained at 37ºC ± 1ºC by means of a circulating water-heating pad.  Breathing rate and heart rate were monitored throughout the course of all imaging sessions.  Rats were positioned in a supine position on a head holder, locally designed and constructed with non-magnetic materials. MR Imaging was performed in a 7T Biospec System (Bruker BioSpin MRI GmBH, Ettlingen, Germany) equipped with a 100 mT/m gradient system.  A birdcage coil of 72 mm inner diameter (Bruker BioSpin MRI GmBH, Ettlingen, Germany) was used for transmission. An actively decoupled surface coil (24 mm diameter) was positioned on the head of the animal for signal reception, to enhance signal-to-noise ratio.  T2-weighted images were acquired using a rapid acquisition with relaxation enhancement (RARE) sequence, with short localizer scans acquired in the sagittal and axial planes (32 sec; resolution = 0.312 mm x 0.312 mm x 1.5 mm).  A higher resolution RARE coronal scan of the brain was acquired with the following parameters: echo time = 34.5 ms; repetition time = 4 sec; number of averages = 2; RARE factor = 8. The field of view was 25.6 mm x 25.6 mm on a 256 x 256 matrix, providing an in-plane resolution of 0.1 mm x 0.1mm. A total of 26 contiguous slices (1 mm thick) were acquired; the scan time was, on average, 4 min 16 sec per animal.  28 2.6 Lesion verification and quantitative assessment  Our MRI technique provided 26 serial coronal sections, 150 sagittal, and 100 axial sections.  MRI analysis focused on various regions of interest, such as CSF-filled tissue loss in ventral (VH) and dorsal hippocampus, and lateral ventricles (Bertrand et al., 2010).  Due to the presence of high concentrations of free water, the lateral ventricles and all lesioned tissue appeared as hypersignals in our T2-weighted images.  Assessment of the lesion volume was performed using the MRI image analysis software, 3D Slicer (www.slicer.org).  Briefly, 3D Slicer allows the user to outline lesion boundaries in all three planes of MR images, affording precise volumetric calculations of the ROI.  Lesion boundaries were defined as regions of hypersignal on T2-weighted images, which indicated areas of tissue loss and ventricle enlargement.  Volumetric calculations of lesion size were performed for all NVHL animals.  Later, the calculated volume was correlated with vDNMS task performance.    2.7 Post-mortem histology and lesion assessment  Following completion of all behavioural testing, rats were deeply anesthetized using Isoflurane.  Rats were then decapitated, at which time their brains were quickly extracted and placed into individual beakers containing a 4% paraformaldehyde-glucose solution, for at least one week.  Coronal sections (40 µm) were collected, beginning when the dorsal-rostral blade of the hippocampus came into view (approximately -2.0 mm AP to bregma; Swanson, 2004).  Sections were collected for slides approximately every 400 µm thus, every 9th-10th section was kept (Chambers and Lipska, 2011).  Sections were stained using a Cresyl Violet stain, and cover slipped.  29 Lesions were evaluated by means of a light microscope to examine cresyl violet stained brain sections.  The coordinates for the NVH lesion target the region of the hippocampus where the CA3 layers of the dorsal and ventral blades convene (Chambers and Lipska, 2011).  Typically, lesioned animals are characterized by one or more of the following neuroanatomical qualities: 1) generalized enlargement of the lateral ventricles; 2) tissue atrophy of the VH; 3) distortion of VH cell layers (Chambers and Lipska, 2011). Animals were disqualified from the current study if there were evidence either or any of the following: 1) that the lesion was a complete hippocampectomy or if the lesion involved significant damage to the dorsal blade of the hippocampus 2) evidence of no lesion or unilateral lesion 3) evidence of significant damage to the surrounding areas (e.g., thalamus).     Although the use of MRI to calculate lesion volume has been validated in previous studies, as discussed above, we wanted to verify the correspondence between MRI and histological quantification of lesion volume.  To calculate lesion volume from the histological specimens, we captured digital images of each stained brain slice, and imported them into Microsoft® Paint.  Lesion areas were then shaded bright yellow, and imported into MATLAB (The Mathworks, Inc) where a custom script was written to identify and count the number of bright yellow pixels in each histological image of three different animals.  Pixels from all images were then added together and a volume was calculated from the total number of pixels by adding the measurements across each section and multiplying by section thickness (40 µm).   30 2.8 Behavioral analysis  vDNMS performance was analyzed by means of ANOVA with testing day, delay length, and lesion status as the independent factors.  The ANOVA was followed by a Fisher LSD post-hoc test.  The relationship between VH lesion volume and vDNMS performance was evaluated using Pearson’s correlation.                 31 Chapter 3: Results 3.1 Histology and MRI  Lesion verification using MRI indicated ventricular enlargement, and volume reduction of the ventral hippocampus of NVHL animals, consistent with the existing literature (Lipska et al., 1995; Lipska, Aultman, and Verma, 2002).  The present study mainly relied on the use of MRI, as opposed to histological processing, to determine lesion volume as in previous studies (Angst et al., 2007; Macedo et al., 2010; Bertrand et al., 2010; Sandner et al., 2010).  While there is generally a good correspondence between lesion volume calculated using MRI and post-mortem histology, we found that the VH lesion volume obtained from histological analysis of three animals to range from 67% smaller to 11% larger than the volume calculated from the MRI, which we believe is attributable to the inherent flaws in the use of histology to calculate lesion volume (see Fig 2; an idea that will be discussed in Chapter 4).   MRI image analysis indicated no damage to the dorsal hippocampus; however, in some animals, portions of the subiculum and dentate gyrus did sustain damage in the form of cell loss and cavitation—a finding that is consistent with the existing NVHL literature (Lipska et al., 2002; Angst et al., 2007; Bertrand et al., 2010). Two NVHL animals were excluded from the current dissertation due to misplaced, or excessively large, lesions that extended into the dorsal hippocampus or thalamus.  For all other NVHL animals, lesion volumes varied in size from 11.61 mm3 to 63.01 mm3, or 12% to 65% of total hippocampal volume (Fig. 3).  Fig. 4a – 4n shows MRI-generated 3D models of all 14 lesioned animals along with their respective average performance across five days of vDNMS testing, at all delay lengths.   32 3.2 Working memory performance  All NVHL and sham animals were able to learn the vDNMS task, which suggests the absence of impairment in sensory integration, acquisition, or any other non-mnemonic process (Lipska et al., 2002).  Over the three days prior to reaching criterion performance on the 1s DNMS training task, ANOVA indicated significantly lower performance in NVHL animals compared to sham animals (F1, 19 = 9.73, p < 0.01; Fig. 5).  However, no effect of day (F2,63 = 0.43, p > 0.05) or interaction between lesion status and day (F2,63 = 0.19, p > 0.05) was noted in performance of NVHL and sham animals on the 1s DNMS training task.  On the 10s DNMS training task, all animals achieved the criterion of < 10% variability in performance, with a negligible difference in the number of training days required to do so.  Additionally, we compared the performance on the last day of testing at the 1s delay (Fig 5, rightmost bar) versus the average performance across the 3 delays on the first day of variable delay testing (vDNMS; Fig 6). An ANOVA uncovered a main effect of both lesion group (F1,19 = 16.03, p < 0.001) and day (F1,19 = 10.56, p < 0.01); however, no interaction was found (F1,19 = 2.84, p > 0.05). This may be a result of reduced statistical power due to the low numbers of sham animals relative to NVHLs.  In spite of the non-significant interaction effect, it was nevertheless important to determine whether or not the difference in performance on the day prior (Fig 5) could solely account for the deficit observed on the first day of variable delay testing (Fig 6).  In other words, did the lesion animals perform poorly at variable delays simply because they had not acquired the task rule as well as the shams?  Tukey’s HSD post-hoc test on these data showed that the sham versus lesion groups did not differ in terms of their performance on the last day of testing at the 1s delay (p = 0.54; Fig 5, rightmost bars). However the groups did differ significantly in their average performance on the first day of  33 vDNMS testing (p = 0.004, Fig 6). Likewise, in terms of within group comparisons, the performance of the sham animals did not differ on the last day of testing at the 1s delay versus the first day of vDNMS testing (p = 0.73), while the performance of the lesioned animals did (p = 0.0028). Therefore, the difference in performance between the groups on the first day of vDNMS testing was much larger than the difference in performance between the groups on the day prior. That is even though the lesioned animals were slightly impaired relative to shams prior to imposing variable delays, the imposition of longer delays impaired the performance of NVHL animals to a greater extent than sham animals.   In comparing vDNMS performance of the NVHL and sham animals across all five days of testing, a three-way ANOVA uncovered significant main effects of lesion status (F1,21 = 12.81, p = 0.002), delay length (F2,63 = 4.22, p = 0.02),  and day of testing (F4,105 = 3.36, p = 0.01).  That is, NVHL animals performed significantly worse than sham animals at all delay lengths and across all days of testing in our vDNMS task (Fig. 6).  However, three-way ANOVA failed to uncover statistically significant interaction effects between the previously mentioned variables.  Taken together with our finding of impaired performance on the 1s DNMS task, the findings of the vDNMS task are indicative of a delay-independent WM deficit in NVHL animals.  Nevertheless, we probed any potential interaction using Fisher’s LSD post-hoc test and found no significant effect between lesion status and delay length (Fisher’s LSD test; p > 0.05).  3.3 Relationship between working memory performance and lesion volume  Within the NVHL group, Pearson’s correlation revealed no statistically significant relationship between lesion volume and vDNMS task performance (see: Fig. 7), at either the  34 10s (r = -0.20, p > 0.05), 20s (r = 0.12, p > 0.05), or 30s (r = 0.15, p > 0.05) delay length.  That is, WM deficits observed in NVHL animals were not significantly influenced by lesion volume.  The absence of this relationship was evident at all delay lengths examined.  Similarly, no statistically significant correlation was observed between lesion volume and days to criterion on the 10s DNMS task (r = -0.24, p > 0.05; Fig. 8).                   35 Chapter 4: Discussion  Findings of the current study indicate that a neonatal ventral hippocampal lesion using the excitotoxin, ibotenic acid, impairs working memory performance in a behavioural paradigm that is reliant on the PFC, consistent with previous reports (Sanchez-Santed et al., 1997; Aultman and Moghaddam, 2001; Lipska et al., 2002).   The results suggest a generalized reduction in working memory performance in lesioned relative to sham animals.  We observed no evidence of a delay-dependent amplification of the WM impairment as there was no statistically significant difference in NVHL animal performance at 1s, 10s, 20s, and 30s delay lengths. The generalized attenuation of vDNMS task performance in our NVHL animals compared to sham animals is most consistent with a deficit during the encoding period of the WM task.  4.1 Discrepant findings in the NVHL literature Overall, it is difficult to compare the findings of the current study to the existing NVHL WM literature due to the large degree of heterogeneity in the methodology employed by individual studies.  For example, some studies do not look at delay-dependent WM (e.g., Wood, Quirion, and Srivastava, 2003) and, others that do, either use extended delay periods in which the animal is not actively maintaining the WM representation (Lipska et al., 2002; Brady, Saul, and Wiest, 2010; Naert et al., 2013) or do not employ the use of variable delay lengths (Brady, Saul, and Wiest, 2010; Heuer and Bachevalier, 2011; Naert et al., 2013).  Because of such differences, we are limited in the number of studies that have assessed delay-dependent spatial WM.  36 In one related study, Brady, Saul, and Wiest (2010) tested WM deficits of NVHL animals in a radial-arm maze spatial delayed win-shift task.  In this task, animals were allowed to explore four arms of a radial-arm maze, which were baited with food, during a sample run.  Then, after a 5 min or 30 min delay interval, animals were reintroduced to the maze where all eight arms were opened, and only the four previously closed arms were baited.   The authors that NVHL performance was significantly reduced, compared to sham animals, at the 30 min delay (Brady, Saul, and Wiest, 2010).  Unfortunately, however, data from the 5 min delay training sessions were not reported thus, preventing any conclusions from being made about the delay-dependency of their NVHL animals’ performance. Marquis, Goulet, and Dore (2008) assessed whether the NVHL manipulation was capable of disrupting delayed alternation performance in rats at PD22, the earliest developmental stage of WM ability.  Similar to the findings of the current study, Marquis, Goulet, and Dore (2008) found that PD22 NVHL rats displayed delay-independent deficits in WM, on delays ranging from 0 to 30 seconds, in support of our finding of a delay-independent impairment.  Conversely, a study by Lipska et al. (2002) found that NVHL animals displayed delay-dependent WM deficits on a task similar to the one employed in the current dissertation.  A plausible explanation for the discrepant findings between the two studies may lie in the variable delay lengths chosen by each group (additional explanations are presented in the following sections).  For example, the current dissertation used closely-spaced delay lengths of 10s, 20s, and 30s on testing days; whereas, Lipska et al. (2002) used more salient delay lengths of 1s, 10s, and 40s.  We suggest the possibility that the use of an extended 40s delay period by Lipska et al. (2002) may have resulted in a delay-dependent WM deficit because the likelihood of becoming distracted by both internal or external events may have been  37 augmented by time.  Further, such an effect would be exaggerated in NVHL animals, which have been shown to be particularly vulnerable to interference (Tseng et al., 2009).  Thus, we argue that use of such extended delay lengths as those employed by Lipska et al. (2002) and Brady, Saul, and Wiest (2010), impose unrealistic and excessive constraints on WM, especially considering that visual WM representations in most human tasks, are largely used for a period no longer than several hundred millisecond to a few seconds (Luck, 2008).  There are a number of factors, other than delay-length that also need to be considered when comparing studies utilizing the NVHL model. For one, severity of lesion-induced impairments in NVHL animals has been attributed to genetic diversity (Lipska and Weinberger, 1995).  Specifically, Lipska and Weinberger (1995) found that Sprague-Dawley, Fisher 344, and Lewis rats receiving small or large NVH lesions exhibited differences in the age of onset and severity of positive-like symptoms.  Strain differences in cognitive performance are also well documented, with pigmented and albino rat strains showing differences in performance on spatial memory tasks (Hort et al., 2000).  Additionally, differences in morphological changes following hippocampal insult have also been observed across different strains, with Long-Evans rats showing more extensive changes to CA1 and CA3 subfields than Wistar rats, in a model of epileptic seizures (Hort et al., 2000).  The above findings suggest that genetic differences among varied strains of rat may confer susceptibility to differential expression of the NVHL phenotype and, potentially, to latent traits seen in schizophrenia (Lipska and Weinberger, 1995; Harrison and Weinberger, 2005; Tseng et al., 2009).  Indeed, such inter-strain genetic diversity may contribute to the expression of delay-independent WM deficits seen in our NVHL animals.  However, this is not to say that the delay-independent WM deficits we found are simply an artifact of the strain of rat we used.   38 Rather, what we suggest is the possibility that strain differences in hippocampal and prefrontal response to the NVH insult may partially contribute to the delay-independent WM performance seen in our animals.  Yet another potential contributing factor to our animals’ delay-independent WM performance may result from their age at testing and its effect on the cholinergic system.  For example, it has been shown that aged, compared to young, Long-Evans rats display marked reductions in acetylcholine binding in the medial septum and vertical limb of the diagonal band (vDB), a region where basal forebrain cholinergic neurons are located (Gill and Gallagher, 1998).   These basal forebrain cholinergic neurons project to the hippocampus, cortex, amygdala, and various other forebrain regions (Lewis and Shute, 1967; McKinney, Miller, and Aagaard, 1983; Amal and Kurtz, 1985).  Interestingly, in young rats, AMPA-induced lesions of the vDB produce a marked decrease in choline acetyltransferase activity and acetylcholine levels in both the cingulate cortex and the hippocampus (McAlonan et al., 1995).  When tested on a spatial DNMS task, vDB lesioned rats displayed a delay-independent performance deficit (McAlonan et al., 1995), much like our NVHL animals.  We propose the possibility that an age related decline in vDB acetylcholine activity (Gill and Gallagher, 1998), in combination with the known reduction in acetylcholine receptor binding in NVHL animals (Laplante et al., 2004; Berg et al., 2014), may lead to a functional lesion of the vDB, thus contributing to the delay-independent WM deficits seen in our animals. Therefore, while our data are roughly consistent with some but not all past NVHL studies, a number of critical factors must be considered before any definitive cross-study conclusions can be drawn.  39 4.2 Absence of a relationship between lesion volume and performance deficit To our knowledge, we are the only group to compare lesion volume against WM deficits, using the NVHL model.  The existing literature appears to primarily use MR imaging with the NVHL model as a means of selecting animals, based on laterality and qualitative assessment of lesion size (e.g., small, medium, large) (Macedo et al., 2008; Macedo et al., 2010; Sandner et al., 2012).  The sparse NVHL literature that does use MRI to calculate lesion volume, often does so to monitor the size of a lesion over time (Bertrand et al., 2010; Sandner et al., 2010).  Nonetheless, our exclusive use of MRI instead of histology to calculate lesion volume is supported by the existing literature (presented earlier).  The lack of correspondence between lesion size assessed with MRI versus post-mortem histology was at first glance, troubling. The histologically based lesion volume estimates ranged from 67% smaller, to 11% larger, than those obtained from the same animals using MRI and were on average 30.1 % smaller.  However, there are a number of possible factors that could have lead to over- as well as under-estimation errors in lesion volume from port-mortem histological analyses.  First, in live NVHL animals, CSF flowing through the enlarged ventricles will exert outward pressure on the surrounding tissue. In contrast, in the ex-vivo brain prepared for histology, no such outward pressure exists from CSF, and the brain tissue surrounding the enlarged ventricle collapses inward, distorting lesion volume estimates (Pfefferbaum et al., 2004). Second, due to ventricle enlargement and cell loss, the NVHL brain is extremely fragile and prone to shearing or tearing during cryostat slicing, which can lead to distorted lesion sizes. Third, the fixative itself can introduce tissue shrinkage (Wehrl et al., 2014) and neurites often appear as shriveled rather than straight, which collectively will also distort the gray and white matter in histological sections (Schrag et al., 2010).   MRI performed in living animals circumvents all  40 these issues and therefore gives the most accurate estimate of the true lesion volume in our animals.  Nonetheless, if one’s intention is simply to detect the presence or absence of a lesion, then histology is an adequate technique.   However, MRI is the most well-suited technique if one’s intention is to accurately assess lesion volume, which was an objective of the current dissertation.  For these reasons, we calculated lesion volumes from MRI in all of our analyses.   Our finding that lesion volume does not correlate with WM performance seems to suggest that, beyond a certain point, any developmental disturbance of VH activity, or its connectivity to the PFC, is detrimental to spatial WM performance as an adult.  As well, the absence of a correlation between VH lesion volume and spatial WM may be interpreted to suggest that a specific region of the VH network, which was damaged by the developmental lesion, may serve as a critical substrate in spatial WM.  That is, there may exist a critical region or threshold volume of VH lesion necessary for the developmentally-delayed expression of the NVHL cognitive phenotype beyond which, there is no additional behavioural deficit as assessed by our vDNMS WM task.   The idea that there exists a volume threshold for effective lesions is also reflected by the work of Moser et al. (1993) who found a threshold value of 20% dorsal hippocampal damage was necessary to produce deficits in spatial learning in Long-Evans rats.  Zola-Morgan et al. (1992) also reported that no less than 24% CA1 field damage was required to produce performance impairments in a DNMS recognition memory task in monkeys.  Interestingly, Moser et al. (1993) reported a correlation between dorsal hippocampal lesion volume and spatial learning; however, no such correlation was observed with ventral hippocampal lesions.  Our smallest lesion encompassed 12% of the total VH volume, which  41 was able to create a WM deficit similar to an animal whose lesion covered 65% of the total VH volume.  The differences between the findings of the current thesis and that of both Moser et al. (1993) and Zola-Morgan et al. (1992) may likely be explained either by the difference in age at which animals were lesioned, the lesion target, how the lesion was achieved, or a combination of all three factors.  For example, both Moser et al (1993) and Zola-Morgan et al. (1992) inflicted aspiration and ischemic lesions, respectively, to adult animals thus, overlooking the impact that a neonatal excitotoxic lesion would have on prefrontal development.  As a result, the NVHL model may serve as a more sensitive tool to study WM deficits in schizophrenia, due to the seemingly lower threshold volume necessary to achieve an effective lesion.  In line with the idea of a threshold volume or critical region of VH lesion, the absence of a correlation between lesion volume and WM performance may result from how the functional capacity of the hippocampus is impaired by lesions.  For example, it may be the case that hippocampal function is more sensitive to smaller lesions, as a result of the way this structure is functionally organized (Baxter and Murray, 2001).  If this were true, and assuming behavioural changes were a direct result of hippocampal damage, more expansive hippocampal lesions would mimic the behavioural changes seen after smaller lesions (Baxter and Murray, 2001).  Indeed, this seems to be reflected in our data.   It should also be noted that there exists a variant of the NVHL model, which involves reversible inactivation of the hippocampus by means of the Na+ channel blocker TTX on PD7 (Lipska and Weinberger, 2002). Though the use of TTX does not produce a physical lesion, it does recapitulate most of the deficits caused by the excitotoxic lesion, although to a lesser degree (e.g., less pronounced WM deficits) than that resulting from an excitotoxic lesion  42 (Lipska and Weinberger, 2002).  However, this suggests that even transient loss of VH activity during a developmentally sensitive time point is capable of causing permanent changes to the normal development of the neural pathways that mediate select dopamine- and NMDA-dependent behaviours (Lipska and Weinberger, 2002). However, one must also acknowledge the possibility that lesion volume (i.e., ventricular enlargement) is not the primary determinant of developmentally delayed behavioural deficits seen in the NVHL model—a seemingly plausible scenario in light of the TTX lesion literature, presented above.  For example, demyelination may be the primary determinant in the expression of cognitive deficits seen in our NVHL animals.  Schneider and Koch (2005) showed that lesions of the mPFC using IBO in PD7 rats led to a significant loss of myelination in some efferent projections of the mPFC (e.g., hippocampus, thalamus, nucleus accumbens, and amygdala) in adulthood.  These reductions in myelination were associated with impulsivity and pre-pulse inhibition deficits in the lesioned animals when they were tested as adults.  Interestingly, findings of myelination reductions in schizophrenia patients are known to exist and are thought to result from a developmental disruption of oligodendrocyte function (Davis et al., 2003; Schneider and Koch, 2005).  In clinical schizophrenia, oligodendrocyte and myelin dysfunction has been linked to cognitive symptoms with patients presenting with such dysfunction showing more severe cognitive dysfunction (Nestor et al., 2004; Fields, 2008; Cocci et al., 2009).  Thus, future NVHL experiments may be aimed at employing the use of diffusion tensor imaging, along with structural MRI, in an effort to dissociate the contributions of ventricular enlargement and demyelination to the emergence of WM deficits.   43 Finally, it should be noted that a relationship between the volume of the AH (the human analog of the rat VH) and symptom severity in schizophrenia patients is unclear.  For example, in patients with childhood onset schizophrenia, findings of bilateral inward deformation in AH correlated positively with the severity of positive symptoms (Johnson et al., 2013).  Conversely, outward deformations in AH were positively correlated with measures of overall functioning (Johnston et al., 2013).  Overlooked, however, is the relationship between AH shape or size abnormality and direct measures of WM.  Unlike the findings of Johnson et al. (2013), Csernansky et al. (2002), despite noting significant abnormalities in AH shape and asymmetry, found no evidence of a relationship between the magnitude of AH abnormality and symptom severity or illness duration across 52 adult patients; whereas, Bilder et al. (1995) found a weak (r = < 0.2) yet significant correlation between AH volume and memory performance in patients.  Considering the studies above, it becomes clear that the evidence linking AH structural abnormalities and cognitive symptoms, specifically WM deficits, in schizophrenia patients is inconclusive.  Such inconclusive findings may result from the fact that, for the most part, research has been aimed at understanding the link between hippocampal abnormalities and positive or negative symptom severity, with significantly less effort directed at understanding the link between hippocampal abnormalities and cognitive symptom severity.  Nonetheless, the fact that there exists no studies which show overwhelmingly convincing evidence of a clinically significant relationship between AH volume abnormalities and cognitive symptoms adds support to our previous hypothesis that WM deficits in schizophrenia are driven by factors other than reductions in hippocampal volume or ventricular enlargement.   44 4.3 Is delay-independent WM a feature of PFC damage? Although the actual excitotoxic lesions were delivered to the hippocampus, it is believed that many of the cognitive deficits, such as those in WM, are actually the result of downstream changes in the PFC (Lipska, Al-Amin, and Weinberger, 1998; O’Donnel et al., 2002; Wood, Quirion, and Srivastava, 2003).  For example, many of the behavioural changes that accompany NVH lesions are behaviours largely reliant on a properly functioning PFC, such as WM, cognitive flexibility, and amphetamine-induced hyperlocomotion. Indeed the delay-independent deficit on a WM task reported here, is also a feature of adult PFC lesions in isolation. For instance, following a bilateral NMDA-induced lesion of the dorsomedial prefrontal cortex (DMPFC), rats showed delay-independent performance deficits in a T-maze spatial WM paradigm (Sanchez-Santed et al., 1997).  Similar delay-independent findings were also found in rats on a delayed non-match to position task, following excitotoxic lesions of the prelimbic cortex (Chudasama and Muir, 1997), as well as NMDA receptor blockade in the DMPFC (Juhana and Paavo, 1999).  This same pattern of WM deficits was also observed in a delayed match to position task, following infusion of the cholinergic antagonist scopolamine into the mPFC (Herremans et al., 1996). Such delay-independent effects on WM performance following PFC lesions are also seen in non-spatial tasks.  Following radiofrequency lesions to the mPFC, Porter, Burk, and Mair (2000) reported that adult rats exhibit delay-independent performance deficits in a retractable lever delayed match-to-sample task. Therefore, direct PFC damage can lead to a pattern of WM deficits that parallels the WM deficits found in the NVHL animals of the current dissertation.  The delay-independent effects discussed above for the rodent literature are also consistent with the results of parallel studies in non-human primates.  In a nonspatial two- 45 object alternation task (for detailed description, see Petrides, 1995), monkeys with mid-dorsal lateral frontal cortex (LFC) lesions were found to perform significantly worse than control yet the deficit was delay-independent. Furthermore, lesioned animals eventually improved to the same level as control animals (Petrides, 1995).  Petrides (1995; 1996) also had animals perform a self-ordered task in which they had to monitor two or three different stimuli, with a fixed delay length of 10 seconds.   In this task, LFC animals performed significantly worse than control animals when they were required to monitor three different stimuli over the delay period.  Thus, unlike delay length, the number of stimuli monitored within WM is a critical factor determining whether or not LFC lesions will result in an impairment of performance.  These studies therefore are consistent with the claim that a delay-independent WM deficit is consistent with damage to the PFC.  4.4 From specific regions to pathways While NVHL lesions produce a deficit similar to an adult PFC lesion, the same deficit is not produced by neonatal PFC lesions. In fact, neonatal PFC lesions do not result in a WM deficit whatsoever when animals are tested in adulthood.  For example, de Brabander, de Bruin, and ven Eden (1990) lesioned the PFC of PD 6 rat pups and when tested on a spatial delayed-alternation WM task in adulthood, their performance was no different than the performance of control animals.  Similarly, Schwabe et al. (2004) delivered excitotoxic lesions to the PFC of PD7 rat pups, and found that WM performance on a spatial delayed-alternation task was spared in adulthood.  Finally, a study by Carter et al. (1995) reported while that rats with neonatal mPFC lesions displayed a delay-independent WM deficit when tested at PD 21 and 22, they performed no different from controls by PD 28.    46 The ability of neonatally PFC lesioned rats to ultimately show normal WM performance may be due to the ability of the developing PFC and its connections to reorganize and possibly regenerate neurons damaged early in life (Schwabe et al., 2004).  This somewhat surprising conjecture is supported by studies showing normal morphology in the regions of remaining PFC directly outside the lesioned area of adult animals that received PFC lesions as neonates (de Brabander, de Bruin & van Eden, 1990; Kolb and Gibb, 1990; Kolb and Gibb, 1993; Schwabe et al., 2004).  For example, PD10 PFC lesioned rats show no difference in dendritic arborization and spine density of layer II-III pyramidal cells at PD60 when compared to control animals (Kolb and Gibb, 1993).   In contrast, no such recovery of morphology is observed in the adult VH following a NVH lesion, suggesting a hindered capacity of the developing VH, and its associated projections to other cortical regions, to recover from insult when compared to the capacity of the developing PFC. This suggests that the NVHL may produce enduring abnormalities in the VH-PFC circuitry that may ultimately prove more detrimental than having no PFC at all. Accordingly, postpubertal PFC lesions in NVH lesioned animals are actually able to restore behavioural (Lipska and Weinberger, 1998) and electrophysiological (Goto and O’Donnell, 2004) deficits resulting from the NVHL manipulation.  Therefore, to the extent that the NVHL models the cognitive deficits in schizophrenia, it would seem that the cognitive deficits in these patients are not the direct result of damage to the hippocampus or PFC but rather dysregulation in the VH-PFC pathway.   47 4.5 The underlying nature of the WM deficit in the NVHL model and schizophrenia As highlighted above, a central aspect of the WM impairment in NHVL rats was its delay-independence. Notably, delay-independence is also a characteristic of the WM deficit observed in patients with schizophrenia. For example, Gold et al. (2010), as well as an earlier meta-analysis by Lee and Park (2005), both reported an absence of a delay-dependence in the WM task performance of schizophrenia patients.  Specifically, in a colour-matching task (for a complete task description, see Gold et al., 2010) of visual WM, schizophrenia patients have been shown to display a delay-independent impairment in task performance at multiple delay lengths.  Further, it was noted that the standard deviation in patient performance (i.e., the error in patient-recalled colour, compared to the actual cued colour) was no different from that of control participants, which was taken to be suggestive of spared WM precision in patients (Gold et al., 2010).  Consistent with the effects of PFC lesions reviewed above, a deficit in patient WM capacity was evidenced by a reduction in the number of items patients were able to maintain in WM (Gold et al., 2010).  In general, WM capacity rather than delay-duration seem to be a key factor in the WM deficits of schizophrenia patients (e.g., Condray et al., 1996; Goldberg et al., 1998; Gold et al., 2003), consistent with what we have found in the NVHL animal model of schizophrenia.   What are the implications of a delay-independent WM deficit for mechanistic theories of schizophrenia?  One popular view is that in schizophrenia WM representations may be characteristically unstable or noisy as a result of decreased stability of the attractor states that are thought to represent information with PFC networks (Lisman et al., 2008; Rolls et al., 2008; Durstewitz & Seamans 2008).  If the attractor states that maintain WM information in  48 PFC were inherently unstable or susceptible to collapse due to noise or distraction in schizophrenia patients, then the likelihood of such collapse would be directly related to the delay interval. In other words, these theories predict the presence of a delay-dependent WM impairment. I would therefore argue that the delay-independent WM deficit in our NVHL animals is not likely a result of unstable WM maintenance in the PFC but rather impaired or noisy information encoding.  An inability to initially form an internal representation of the WM task during the encoding stage would result in a WM deficit that is delay independent because, if the animals encoded the wrong stimulus or aspect of the vDNMS task, WM errors would occur irrespective of delay length.  In accordance with this view, evidence of a slowed encoding process has been reported for schizophrenic patients by Hartman et al. (2002) who found that increasing the duration of stimulus presentation augmented patient performance in a visuospatial WM task.  Additionally, Lee and Park (2002) found that increasing the attentional salience of target objects in a visuospatial WM task seemed to facilitate patient performance.    The underlying cause of the proposed aberrant encoding in our rats, just as in the human literature, is unclear; however, several explanations are plausible.  In line with Hartman et al. (2002), it may be the case that our NVHL animals require a longer encoding period in order to form precise mental representations of the WM task. Another possibility is that poor encoding by our NVHL animals may be due to a reduced ability to select relevant information from, or efficiently direct their attention to, relevant features of the WM task (Adler et al., 1998; Braver, Barch, and Cohen, 1999; Lee and Park, 2005).  Such deficits may be the cause of imprecise encoding, encoding of the wrong stimuli, or both, in our NVHL animals as well as in schizophrenic patients.    49 While encoding deficits are the most parsimonious explanation for a delay-independent WM deficit, it should be noted that even in experiments that allowed for optimized encoding, deficits in spatial WM were still observed in schizophrenia patients (Park, Swisher, and Knurek, 2001; Lee and Park, 2002).  Therefore, the potential contributions of dysfunctional maintenance and/or retrieval processes cannot be excluded.  Future studies are therefore required to disentangle the individual contributions of each WM element and their individual role in the cognitive deficits seen in schizophrenia patients.  4.6 Conclusion  The current dissertation provides insight into the contributions of developmental changes in neuro-physiological, -anatomical, and -chemical systems towards the expression of wokring deficits in schizophrenia.  A major point of contention in Neuroscience is the ability to effectively translate the implications of basic research findings from the bench to the bedside.  In order to bridge this translational gap, animal models must accurately reproduce behavioural endpoints that characterize patient illness.  The current dissertation found that neonatal ventral hippocampal lesion volume did not correlate with performance deficits on a vDNMS task, suggesting that lesion volume alone cannot explain for the variance in working memory deficits in our NVHL animals.  Additionally, it was found that NVHL animals display delay-independent deficits on a vDNMS task of working memory, which are consistent with deficits during the encoding stage of working memory.  These two findings are consistent with those of the existing literature on schizophrenia patients.   50 Figures  Figure 1.  Illustration of T-maze configuration.    Each trial was composed of a “forced” and “choice” run, in that order.   Beginning with the “forced” run, animals started in the “start” location and would travel down the stem, towards the two perpendicular choice arms, where either the left or right choice door was closed.  This forced the animals down the opposite arm, where they would then travel back to the start location, via the return arm.  This commenced the end of the “forced” run.  Upon returning to the “start” location, animals were contained there via closure of the return doors and stem door, for the specified delay time (10s, 20s, or 30s).  Following the end of the delay period, the “choice” run would begin by opening the stem door and both choice arm doors, giving them free access to either choice arm.  In order to receive a food reward, animals were required to travel back down the stem and into the arm opposite the one visited in the “forced” run.  51                         Figure 2.  Illustration of disadvantages in using histology for lesion volume calculations.  Images show a common issue encountered when using histology to determine lesion volume.  Figures 2a) and 2b) are taken from two different animals, at roughly -3.5 mm and -3 mm from bregma, respectively.  Red arrows indicate areas of ventricular enlargement and tissue loss. Figure 2a) Lack of CSF in the ex-vivo brain (left) causes outlying tissue to collapse inward.  Thus, calculation of lesion volume from histology can lead to an underestimate of true lesion volume obtained from MRI. Figure 2b) Due to the delicate nature of lesioned tissue, histological processing often causes the damage to the brain, which is especially evident following mounting on a microscope slide.  By contrast, the MRI image on the right shows an accurate picture of what the true lesion extent was in this animal.  Thus, calculation of lesion volume from histology can also lead to an overestimate of the true lesion size obtained from MRI.     Histology MRI a) b)  52                             Figure 3. Comparative images of MRI and histology.  Images depict the MRI and histological views of sham lesioned animals, as well as examples of small and large NVH lesions.  Arrows indicate areas of ventricular enlargement and tissue loss.  Coronal slices were taken at roughly -4 mm and -6 mm relative to bregma.                Sham Small NVHL Large NVHL MRI Histology   Bregma -4 mm Bregma -6 mm  53 Rostral Caudal Rostral Caudal I II III IV 4a)                                     Figure 4a-n. 3D models of NVHL lesion shapes and respective performance.  Figures a) through n) depict the MRI-generated 3D models of lesion volume of each NVHL animal, as well as each animals’ respective vDNMS performance across the five days of testing (bar graph).  Figures are arranged in order of smallest (a) to largest (n) lesion size.  I) Shows coronal view of lesion at most anterior end.  II) Shows coronal view of lesion at most posterior end.  III)  Shows left-sagittal view of lesion.  IV) Shows right-sagittal view of lesion.  For figures III) and IV), “R” and “C” refer to rostral and caudal coordinates, respectively.   54 Rostral Caudal Rostral Caudal I II III IV 4b)                                                55 Rostral Caudal Rostral Caudal I II III IV 4c)                                                56 Rostral Caudal Rostral Caudal I II III IV 4d)                                                57 Rostral Caudal Rostral Caudal I II III IV 4e)                                                58 Rostral Caudal Rostral Caudal I II III IV 4f)                                               59 Rostral Caudal Rostral Caudal I II III IV 4g)                                               60 Rostral Caudal Rostral Caudal I II III IV 4h)                                                 61 Rostral Caudal Rostral Caudal I II III IV 4i)                                                62 Rostral Caudal Rostral Caudal I II III IV 4j)                                                63 Rostral Caudal Rostral Caudal I II III IV 4k)                                                64 Rostral Caudal Rostral Caudal I II III IV 4l)                                                65 Rostral Caudal Rostral Caudal I II III IV 4m)                                                66 Rostral Caudal Rostral Caudal I II III IV 4n)                                               67                    Figure 5.  Comparison of sham and NVHL animals on days preceding criterion performance on the 1s DNMS task   Sham, compared to NVHL, animals performed significantly better on the 1s DNMS task across all three days required to reach criterion performance (defined as at least 80% correct trials over three consecutive days).                   68                                               Figure 6. Daily performance of all animals in the vDNMS task.  NVHL rats performed significantly worse than control animals at all delay lengths and across all days of testing (* p < 0.05).  69                   Figure 7. Relationship between lesion volume and vDMNS performance.    In the NVHL group, ventral hippocampal lesion volume showed no statistically significant relationship with performance deficit at any delay length.                      70              Figure 8.  Relationship between lesion volume and days to reach criterion performance on the 10s DNMS task.   In the NVHL group, lesion volume showed no statistically significant relationship with the number of days required to reach criterion performance (defined as <10% variability in performance) in order to advance to the vDNMS task.                71 Bibliography Abrams R., & Taylor M.A. (1979). Differential EEG patterns in affective disorder and  schizophrenia. Archives of General Psychiatry, 36, 1355–1358. Adler L.E., Olincy A., Waldo M., et al. (1998). Schizophrenia, sensory gating, and  nicotinic receptors. Schizophrenia Bulletin, 24, 189-202. Adriano F., Caltagirone C., & Spalletta G. (2012). Hippocampal volume reduction in  first-episode and chronic schizophrenia: a review and meta-analysis.  Neuroscientist, 18, 180-200. Adriano F., Caltagirone C., Spalletta G. (2012). Hippocampal volume reduction in first- episode and chronic schizophrenia: a review and meta-analysis. Neuroscientist, 18,  180-200. Akbarian S., Kim J.J., Pothin S.G., et al. (1995). Gene expression for glutamic acid  decarboxylase is reduced without loss of neurons in  prefrontal cortex of  schizophrenics. Archives of General Psychiatry, 52, 258– 266. Akbarian S., Kim J.J., Pothin S.G., et al. (1996). Maldistribution of interstitial neurons in  prefrontal white matter of the brains of schizophrenic patients. Archives of General  Psychiatry, 53, 425-4236. Akbarian S., Vinuela A., Kim J.J., et al. (1993). Temporal lobe of schizophrenics implies   anomalous cortical development. Archives of General Psychiatry, 50, 178-187. Al-Amin H.A., Weinberger D.R., & Lipska B.K. (2000). Exaggerated MK-801-induced motor  hyperactivity in rats with the neonatal lesion of the ventral  hippocampus. Behavioural  Pharmacology, 11, 269–278. Alquicer G., Morales-Medina J.C., Quirion R., et al. (2008). Post weaning social isolation  enhances morphological changes in the neonatal ventral hippocampal lesion rat  model of psychosis. Journal of Chemical Neuroanatomy, 35, 179–187. Amaral D.G. and Kurz J. (1985). An analysis of the origins of the cholinergic and  noncholinergic septal projections to the hippocampal formation of the rat.   Journal of  Computational Neurology, 240, 37–59. Ambelas A. (1992). Preschizophrenics: adding to the evidence, sharpening the focus.  British Journal of Psychiatry, 160, 401–404. Andreasen N.C., O’Leary D.S., Cizadlo T., et al. (1996).  Schizophrenia and cognitive  dysmetria: A positron-emission tomography study of dysfunctional prefrontal- thalamic-cerebellar circuitry. Proceedings of the National Academy of Sciences  USA, 93, 9985–9990.  72 Andreasen N.C., O’Leary D.S., Flaum M., et al. (1997). Hypofrontality in schizophrenia:  Distributed dysfunctional circuits in neuroleptic-naive patients. Lancet, 349,  1730–1734. Angst M., Macedo T., Guilberteau T., et al. (2007). Alteration of conditioned emotional  response and conditioned taste aversion after neonatal ventral hippocampus  lesions in rats. Brain Research, 1143, 183-192.  Arnold S.E., Franz B.R., Gur R.C., Gur R.E., Shapiro R.M., Moberg P.J., & Trojanowski  J.Q.  (1995). Smaller neuron size in schizophrenia in hippocampal subfields that mediate  cortical-hippocampal interactions. American Journal of Psychiatry, 152, 738–748. Arnold S.E., Hyman B.T., Van Hoesen V., et al. (1991). Some cytoarchitectural abnormalities  of the entorhinal cortex in schizophrenia. Archives of General Psychiatry, 48, 625-632. Arnold S.E., Ruscheinsky D.D., & Han L.Y. (1997). Further evidence of abnormal  cytoarchitecture of the entorhinal cortex in schizophrenia using spatial point  pattern analyses. Biological Psychiatry, 42, 639–647. Aultman J.M. & Moghaddam B. (2001). Distinct contributions of glutamate and dopamine  receptors to temporal aspects of rodent working memory using a clinically relevant  task. Psychopharmacology, 153, 353–364. Aylward E., Walker E., & Andreasen N.C. (1991). The distinction of positive and  negative  symptoms: The failure of a two-dimensional model.  Britishi Journal of Psychiatry,  158, 317-322. Baddeley A. (1986). Working memory. New York: Oxford University Press. Baddeley A. (1992). Working memory. Science, 255, 556-559. Baddeley A., Gathercole S., & Papagno C. (1998). The phonological loop as a language  learning device. Psychological Reviews, 105, 158-173. Baldessarini R.J., Hegarty J.D., Bird E.D., et al. Meta-analysis of postmortem studies of  Alzheimer’s disease- like neuropathology in schizophrenia. American Journal of  Psychiatry, 154, 861–863. Bannerman D.M., Rawlins J.N., McHugh S.B., et al. (2004). Regional dissociations  within the hippocampus—memory and anxiety. Neuroscience Biobehavioural  Reviews, 28, 273-283. Barch D.M. & Carter C.S. (1998). Selective attention in schizophrenia: Relationship to  verbal working memory. Schizophrenia Research, 33, 53–61. Barch D.M., Sheline Y.I., Csernansky J.G., et al. (2003). Working memory and prefrontal  cortex dysfunction: Specificity to schizophrenia compared with major depression.  Biological Psychiatry, 53, 376-384.  73 Bauer R.H. and Fuster J.M. (1976). Delayed-matching and delayed-response from  cooling dorsolateral prefrontal cortex in monkeys. Journal of Comparative and  Physiological Psychology, 90, 293-302. Baxter M.G. and Murray E.A. (2001). Opposite relationship of hippocampal and rhinal  cortex damage to delayed nonmatching-to-sample deficits in monkeys.  Hippocampus, 11, 61-71. Bazin N., Perruchet P., Hardy-Bayle M., & Feline A. (2000). Context-dependent    information processing in patients with schizophrenia. Schizophrenia Research,   45, 93-101. Beason-Held L.L., Rosene D.L., Killiany R.J., et al. (1999). Hippocampal  formation  lesions produce memory impairment in the rhesus monkey.  Hippocampus, 9,  562–574. Becker A. & Grecksch G. (2000). Social memory is impaired in neonatally ibotenic acid  lesioned rats. Behavioural Brain Research, 109, 137–40. Becker A., Grecksch G., Bernstein H.G., et al. (1999). Social behaviour in rats lesioned with  ibotenic acid in the hippocampus: quantitative and qualitative analysis.  Psychopharmacology, 144, 333–338. Benes F.M., McSparren J., Bird E.D., et al. (1991). Deficits in small interneurons in  prefrontal and cingulate cortices of schizophrenic and schizoaffective patients.  Archives of General Psychiatry, 48, 996–1001. Benes F.M., Sorensen I., & Bird, E.D. (1991). Reduced neuronal size in posterior  hippocampus of schizophrenic patients. Schizophrenia Bulletin, 17, 597–608. Benes F.M., Vincent S.L., Marie A., et al. (1996). Up-regulation of GABA-A receptor  inding on neurons of the prefrontal cortex in schizophrenic subjects.  Neuroscience, 75, 1021–1031. Benson D.L., Huntsman M.M., & Jones E.G. (1994). Activity-dependent changes in  GAD and preprotachykinin mRNAs in visual cortex of adult monkeys. Cerebral  Cortex, 4, 40–51. Berg S.A., Sentir A.M., Bell R.L., et al. (2014). Nicotine effects in adolescence and  adulthood on cognition and α4β2-nicotinic receptors in the neonatal ventral  hippocampal lesion rat model of schizophrenia. Psychopharmacology, 213, 14-38. Berman K.F., Torrey E.F., Daniel D.G., et al. (1992). Regional cerebral blood flow in  monozygotic twins discordant and concordant for schizophrenia. Archives of  General Psychiatry, 49, 927–934. Bernstein H.G., Grecksch G., Becker A., et al. (1999).  Cellular changes in rat brain areas  associated with neonatal hippocampal damage. Neuroreport, 10, 2307–2311.  74 Bertolino A., Knable M.B., Saunders R.C., et al. (1999). The relationship between  dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in  schizophrenia. Biological Psychiatry, 45, 660–667. Bertrand J., Lanlois J., Begou M., et al. (2010). Longitudinal MRI monitoring of brain  damage in the neonatal ventral hippocampal lesion rat model of schizophrenia.  Hippocampus, 20, 264-278. Bilder R., Lipschultz-Broch L., Reiter G., et al. (1992). Intellectual deficits in first- episode patients with schizophrenia: evidence for progressive deterioration.  Schizophrenia Bulletin, 18, 437–448. Bilder R.M., Bogerts B., Ashtari M., et al. (1995). Anterior hippocampal volume  reductions  predict frontal lobe dysfunction in first episode schizophrenia. Schizophrenia  Research, 17, 47-58. Bogarts B., Ashtari M., Degreef G., et al. (1990). Reduced temporal limbic structure  volumes on magnetic resonance images in first episode schizophrenia. Psychiatry  Research, 35, 1–13. Bogarts B., Meertz E., & Schonfeldt-Bausch R. (1985). Basal ganglia and limbic system  pathology in schizophrenia. Archives of General Psychiatry, 42, 784–791. Bogerts B., Falkai P., Haupts M., et al. (1990). Post-mortem volume measurements of  limbic system and basal ganglia structures in chronic schizophrenics. Initial  results from a new brain collection. Schizophrenia Research, 3, 295-301. Boos H.B., Aleman A., Cahn W., et al. (2007). Brain volumes in relatives of patients with  schizophrenia: a meta- analysis. Archives of Geneneral Psychiatry, 64, 297-304. Boyer P., Phillips J.L., Rousseau F.L., & Llivitsky S. (2006). Hippocampal abnormalities  and  memory deficits: New evidence of a strong pathophysiological link in schizophrenia.  Brain Research Reviews, 54, 992-112. Brady A.M., Saul R.D., & Wiest M.K. (2010). Selective deficits in spatial working  memory in the neonatal ventral hippocampal lesion rat model of schizophrenia.  Neuropharmacology, 59, 605-611. Braver T.S., Barch D.M., & Cohen J.D. (1999). Cognition and control in schizophrenia:  A  computational model of dopamine and prefrontal function. Biological Psychiatry, 46,  312–328. Bunney W.E. & Bunney B.G. (2000). Evidence for a compromised dorsolateral  prefrontal  cortical parallel circuit in schizophrenia. Brain Research Reviews, 31, 138–146.  Burgess N., Becker S., King J.A., & O’Keefe J. (2001). Memory for events and their spatial  context: models and experiments. Philosophical Transactions of the Royal Society of  London, Biological Sciences, 356, 1493–1503.  75 Burglen F., Marczewski P., Mitchell K.J., van der L.M., Johnson M.K., Danion J.M., &  Salame P. (2004). Impaired performance in a working memory binding task in patients  with schizophrenia. Psychiatry Research, 125, 247–255. Burk J.A. & Mair R.G. (2001). Effects of dorsal and ventral striatal lesions on delayed  matching trained with retractable levers. Behavioural Brain Research, 122, 67-78. Callicott J.H., Bertolino A., Mattay V.S., et al. (2000). Physiological dysfunction of the  dorsolateral prefrontal cortex in schizophrenia revisited.  Cerebral Cortex, 10,  1078–1092. Callicott J.H., Mattay V.S., Verchinski B.A., et al. (2003). Complexity of prefrontal  cortical dysfunction in schizophrenia: More than up or down. The American  Journal of Psychiatry, 160, 2209–2215. Callicott J.H., Ramsey N.F., Tallent K. et al (1998). Functional magnetic resonance  imaging brain mapping in psychiatry: Methodological issues illustrated in a study  of  working memory in schizophrenia. Neuropsychopharmacology, 18, 186–196. Cannon T.D., Zorrilla L.E., Shtasel D., et al. (1994). Neuropsychological functioning in  iblings discordant for schizophrenia and healthy volunteers. Archives of General  sychiatry, 51, 651-661. Carr D.B. and Sesack S.R. (1996). Hippocampal afferents to the rat prefrontal cortex:  Synaptic targets and relation to dopamine terminals. Journal of Computational  Neurology, 369, 1–15. Carter C.S., Freeman J.H. Jr., & Stanton M.E. (1995). Neonatal medial prefrontal lesions  and  recovery of spatial delayed alternation in the rat: Effects of delay interval.  Developmental Psychobiology, 28, 269–279. Carter C.S., Perlstein W., Ganguli R., et al. (1998). Functional hypofrontality and  working  memory dysfunction in schizophrenia. American Journal of Psychiatry, 155, 1285– 1287. Catafau A.M., Parellada E., Lomena F.J. et al (1994). Prefrontal and temporal blood flow  in  schizophrenia: Resting and activation technetium-99 m-HMPAO SPECT  patterns in  young neuroleptic-naive patients with acute disease. Journal of Nuclear Medicine, 35,  935–941. Cegalis J.A. & Sweeney J.A. (1979). Eye movements in schizophrenia: A quantitative  analysis. Biological Psychiatry 14, 13–26. Censits D., Ragland D., Gur R., et al. (1997). Neuropsychological evidence supporting a  neurodevelopmental model of schizophrenia: a longitudinal study. Schizophrenia  Research, 24, 289–298.  76 Censits D.M., Ragland J.D., Gur R.C., et al. (1997). Neuropsychological evidence  supporting a neurodevelopmental model of schizophrenia : a longitudinal study.   Schizophrenia Research, 24, 289-298. Chambers R., & Lipska B.K. (2011). A method to the madness: Producing the neonatal  ventral hippocampal lesion rat model of schizophrenia.  In Animal models of  schizophrenia and related disorders. 1st ed. Totowa, NJ: Humana Press. Chambers R.A.,Krystal J.H., & Self D.W. (2001). A neurobiological basis for substance  abuse comorbidity in schizophrenia. Biological Psychiatry, 50, 71–83. Chambers R.A.,Moore J.,McEvoy J.P., et al. (1996). Cognitive effects of neonatal  hippocampal lesions in a rat model of schizophrenia. Neuropsychopharmacology,  15,  587–594. Chudasama Y. & Muir J.L. (1997). A behavioural analysis of the delayed non-matching  to  position task: the effect of scopolamine, lesions of the forni, and of the prelimbic  region on mediating behaviours by rats. Psychopharmacology, 134, 73-82. Cocchi L., Walterfang M., Testa R., et al. (2009). Grey and white matter abnormalities are  associated with impaired spatial working memory ability in first-episode   schizophrenia. Schizophrenia Research, 115, 163-172. Cohen J.D., Braver T.S., & O’Reilly R.C. (1996). A computational approach to prefrontal  cortex, cognitive control and schizophrenia: recent developments and current  challenges. Philosophical Transactions of the Royal Society, 351, 1515–1527. Cohen, J.D. & Servan-Schreiber D. (1992). A neural network model of disturbances in the  processing of context in schizophrenia. Psychiatric Annals, 22, 131–136. Condray R., Steinhauer S.R., van Kammen D.P., et al. (1996). Working memory capacity  predicts language comprehension in schizophrenic patients. Schizophrenia  Research, 20, 1-13. Conklin H.M., Curtis C.E., Kastanis J., et al. (2000). Verbal working memory impairment  in schizophrenia patients and their first-degree relatives : Evidence from the digit  span  task. American Journal of Psychiatry, 157, 275-277. Conrad A.J., Abebe T., Austin R., Forsythe S., & Scheibel A.B. (1991). Hippocampal  pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Archives of  General Psychiatry, 48, 413–417. Constantinidis C., Williams G.V., & Goldman-Rakic P.S. (2002). A role for inhibition in  shaping the temporal flow of information in prefrontal cortex. Nature  Neuroscience, 5, 175-180. Cools A.R., Brachten R., Heeren D., et al. (1990). Search after neurobiological profile of  individual-specific features of Wistar rats. Brain Research Bulletin, 24, 49–69.  77 Costall B. & Naylor R.J. (1995). Behavioural interactions between 5-hydroxytryptophan,  neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding  to  aversive situations. British Journal of Pharmacology, 116, 2989–2999. Crow T.J., Ball J., Bloom S.R., et al. (1989) Schizophrenia as an anomaly of  development of cerebral asymmetry. Archives of General Psychiatry, 46, 1145– 1150. Csernansky J.G., Wang L., Jones D., et al. (2002). Hippocampal deformities in  schizophrenia characterized by high dimensional brain mapping. American  Journal of Psychiatry, 159, 2000–2006. Curtis V.A., Bullmore E.T., Brammer M.J. et al (1998). Attenuated frontal activation  during a verbal fluency task in patients with schizophrenia. American Journal of  Psychiatry, 155, 1056–1063. Curtis V.A., Bullmore E.T., Morris R.G., et al. (1999). Attenuated frontal activation in  schizophrenia may be task dependent. Schizophrenia Research, 37, 35-44. Dauphinais I.D., DeLisi L.E., Crow T.J., et al. (1990). Reduction in temporal lobe size in  siblings with schizophrenia : A magnetic resonance imaging study. Psychiatry  Research, 35, 137–147. Davatzikos C., Shen D., Gur R.C., et al. (2005). Whole-brain morphometric study of  schizophrenia revealing a spatially complex set of focal abnormalities. Archives of  General Psychiatry, 62, 1218–1227. Davatzikos C., Shen D., Gur R.C., et al. (2005). Whole-brain morphometric study of  schizophrenia revealing a spatially complex set of focal abnormalities. Archives of  Geneneral Psychiatry, 62, 1218-1227. Davidson M., Reichenberg A., Rabinowitz J et al. (1999). Behavioural and intellectual  merkers for schizophrenia in apparently healthy male adolescents. American  Journal of Psychiatry, 156, 1328–1335. Davis K.L., Stewart D.G., Friedman J.I., et al. (2003). White matter changes in  schizophrenia: Evidence for myelin-related dysfunction. Archives of General  Psychiatry. 60, 443-456. De Brabander J.M., de Bruin J.P.C., & van Eden C.G. (1990). Comparison of the effects  of  neonatal and adult medial prefrontal cortex lesions on food hoarding and spatial  delayed alternation. Behavioural Brain Research, 42, 67-75. Durstewitz D. & Seamans J.K. (2008). The dual-state theory of prefrontal cortex dopamine  function with relevance to catechol-O-methyltransferase genotypes and schizophrenia.  Biological Psychiatry, 64, 739-749.  78 Elvevag B. & Goldberg T.E. (2000). Cognitive impairment in schizophrenia is the core of  the disorder. Critical Reviews in Neurobiology, 14¸ 1–21. Falkai P. & Bogerts B. (1986). Cell loss in the hippocampus of schizophrenics. European  Archives of Psychiatry and Clinical Neuroscience, 236, 154–161. Fedorov A., Beichel R., Kalpathy-Cramer J., et al. (2012). 3D Slicer as an image  computing  platform for the quantitative imaging network. Magnetic Resonance Imaging, 30,  1323–1341.  Feldpausch D.L., Needham L.M., Stone M.P., et al. (1998). The role of dopamine D4  receptor in the induction of behavioral sensitization to amphetamine and  accompanying biochemical and molecular adaptations. Journal of Pharmacology  and  Experimental Therapeutics, 286, 497–508. Fields R.D. White matter in learning, cognition and psychiatric disorders. Trends in  Neuroscience, 31, 361-370. Flores G., Alquicer G., Silva-Gomez A.B., et al.  (2005a). Alterations in dendritic  morphology  of prefrontal cortical and nucleus accumbens neurons in post-pubertal rats after  neonatal excitotoxic lesions of the ventral hippocampus. Neuroscience, 133, 463–470. Flores G., Silva-Gomes A.B., Barbeau D., et al. (2005b). Effect of  excitotoxic lesions of the  neonatal ventral hippocampus on the immobility response in rats. Life Sciences, 76,  2339-2348. Forbes N.F., Carrick L.A., McIntosh A.M., & Lawrie S.M. (2009). Working memory in  schizophrenia: A meta-analysis. Psychological Medicine, 39, 889-905. Friston K.J. & Frith C.D. (1995). Schizophrenia: a disconnection syndrome? Clinical  Neuroscience, 3, 89–97. Funahashi S., Bruce C.J., and Goldman-Rakic P.S. (1993). Journal of Neuroscience, 13,  1479–1497. Gill T.M. and Gallagher M. (1998). Evaluation of muscarinic M2 receptor sites in basal  forebrain and brainstem cholinergic systems of behaviourally characterized young  and aged Long-Evans rats. Neurobiology of Aging, 19, 217–225. Godsil B.P., Kiss, J.P., Spedding M., et al. (2013). The hippocampal-prefrontal pathway:  The  weak link in psychiatric disorders? European Neuropsychopharmacology, 23, 1165- 1181. Gogos J.A. & Gerber D.J. (2006). Schizophrenia susceptibility genes: emergence of  positional candidates and future directions. Trends in Pharmacological Science, 27,  226–33.  79 Gold J.M. & Harvey P.D. (1993). Cognitive deficits in schizophrenia. Psychiatric Clinics  of North America, 16, 295-312. Gold J.M. (2004). Cognitive deficits as treatment targets in schizophrenia. Schizophrenia  Research, 72, 21–28. Gold J.M., Carpenter C., Randolph C., et al., (1997). Auditory working memory and  Wisconsin Card Sorting Test performance in schizophrenia. Archives in General  Psychiatry, 54, 159–165. Gold J.M., Hahn B., Zhang W.W., et al. (2010). Reduced capacity but spared precision and  maintenance of working memory representations in schizophrenia. Archives in  General Psychiatrty, 67, 570–577. Gold J.M., Wilk C.M., McMahon R.P., et al. (2003). Working memory for visual features  and conjunctions in schizophrenia. Journal of Abnormal Psychology, 112, 61-71. Goldberg E. & Seidman L. (1991). Higher cortical functions in normals and in  schizophrenia: a selective review, in Neuropsychology, Psychophysiology and  Information Processing: Handbook of Schizophrenia, vol 5. Edited by Steinhauser  S, Gruzelier J, Zubin J. Amsterdam, Elsevier, 1991, pp 553–597. Goldberg T.E., & Weinberger D.R. (1988). Probing prefrontal function in schizophrenia with  neuropsychological paradigms. Schizophrenia Bulletins, 14, 179–183. Goldberg T.E., & Weinberger D.R. (1996). Effects of neuroleptic medications on the  cognition of patients with schizophrenia: a review of recent studies. Journal of  Clinical Psychiatry, 57, 62–65. Goldberg T.E., Kelsoe J.R., Weinberger D.R., et al. (1988). Performance of  schizophrenic  patients on putative neuropsychological tests of frontal lobe  function. International Journal of  Neuroscience, 42, 51–58. Goldberg T.E., Patterson K.J., Taqqu Y., et al. (1998). Capacity limitations in short-term  memory in schizophrenia: tests of competing hypotheses. Psychological Medicine, 28,  665-673. Goldberg T.E., Torrey E.F., Gold J.M., et al. (1993). Learning and memory in  monozygotic twins discordant for schizophrenia. Psychological Medicine, 23,11- 85. Goldberg T.E., Torrey E.F., Berman K.F., et al. (1993). Relations between neuropsychological  performance and brain morphological and physiological measures in monozygotic  twins discordant for schizophrenia. Psychiatry Research: Neuroimaging, 55, 51-61. Goldberg T.E., Weinberger D.R., Berman K.F., et al. (1987). Further evidence for  dementia of the prefrontal type in schizophrenia? A controlled study of teaching the  Wisconsin Card Sorting Test. Archives in General Psychiatry, 44, 1008–1014.  80 Goldman M.B. & Mitchell C.P. (2004). What is the functional significance of  hippocampal pathology in schizophrenia? Schizophrenia Bulletin, 30, 367–392. Goldman-Rakic P. (1991). Prefrontal cortical dysfunction in schizophrenia: the relevance  of  working memory. In: Carroll, B.J., Barrett, J.E. (Eds.), Psychopathology and  the  Brain. Raven Press, New York, pp. 1–23.  Goldman-Rakic P. (1994). Working memory dysfunction in schizophrenia. Journal of  Neuropsychiatry and Clinical Neurosciences, 6, 348–357. Goldman-Rakic P. (1996). The prefrontal landscape: Implications of functional architecture  for understanding human mentation and the central executive. Philosophical  Transactions of the Royal Society of London: Biological Science, 351, 1445–1453. Goto Y. & O’Donnell P. (2002). Delayed mesolimbic system alteration in a  developmental animal model of schizophrenia. Journal of Neuroscience, 22,  9070–9077. Grace A.A. (2000). Gating of information flow within the limbic system and the  pathophysiology of schizophrenia. Brain Research, 31, 330–341. Grecksch G., Bernstein H.G., Becker A., et al. (1999). Disruption of latent inhibition in rats  with postnatal hippocampal lesions. Neuropsychopharmacology, 20, 525– 532. Green M.F., Kern R.S., Braff D.L., et al. (2000). Neurocognitive deficits and functional  outcome in schizophrenia: are we measuring the “right stuff”? Schizophrenia  Bulletins, 26, 119–136. Guidotti A., Auta J., Davis J.M., et al. (2000). Decrease in reelin and glutamic acid  decarboxylase67 (GAD67 ) expression in schizophrenia and bipolar disorder.  Archives of Geneneral Psychiatry, 57, 1061–1069. Gur R.E., Turetsky B.I., Bilker W., et al. Reduced gray matter volume in schizophrenia.  Archives of General Psychiatry, 56, 905–911. Harrison P.J. & Weinberger D.R. (2005). Schizophrenia genes, gene expression, and  neuropathology: on the matter of their convergence. Molecular Psychiatry,10, 40– 68. Harrison P.J. (1997). Schizophrenia: a disorder of neurodevelopment? Current Opinions  in  Neurobiology, 7, 285–289. Harrison P.J. (2004). The hippocampus in schizophrenia: A review of the  neuropathological  evidence and its pathophysiological implications. Psychopharmacology, 174, 151– 162. Hartman M., Steketee M.C., Silva S., et al. (2002). Working memory and schizophrenia:  Evidence for slowed encoding. Schizophrenia Research, 59, 99-113.  81 Hasan A., Wobrock T., Falkai P., et al. (2011). Hippocampal integrity and neurocognition  in first-episode schizophrenia: a multidimensional. World Journal of Biological  Psychiatry, 15, 188-199. Heaton R., Paulsen J., McAdams L., et al. (1994). Neuropsychological deficits in  schizophrenics: relationship to age, chronicity, and dementia. Archives of General  Psychiatry, 51, 469–476. Heaton R.K., Gladsjo J.A., Palmer B.W., et al. (2001). Stability and course of  neuropsychological deficits in schizophrenia. Archives of General Psychiatry, 58,  24- 32.  Heckers S., Rauch S., Goff D., et al. (1998).  Impaired recruitment of the hippocampus  during conscious recollection in schizophrenia.  Nature Neuroscience, 1, 318-323. Heinrichs R.W. & Zakzanis K.K. (1998). Neurocognitive deficits in schizophrenia: a  quantitative review of the evidence. Neuropsychology, 12, 426-445. Herremans A.H.J., Hijzen T.H., Welborn P.F.E., et al. (1996). Effects of infusion of  cholinergic drugs into the prefrontal cortex area on delayed matching to position  performance in the rat. Brain Research, 711, 102-111. Heuer E. & Bachevalier J. (2011). Neonatal hippocampal lesions in rhesus macaques alter the  monitoring, but not maintenance, of information in working memory. Behavioural  Neuroscience, 125, 859-870. Ho B.C., & Magnotta V. (2010). Hippocampal volume deficits and shape deformities in  young biological relatives of schizophrenia probands. Neuroimage, 49, 3385– 3393. Ho B.C., Andreasen N.C., Nopoulos P., et al. (2003). Progressive structural brain  abnormalities and their relationship to clinical outcome: A longitudinal magnetic  resonance imaging study early in schizophrenia. Archives of General Psychiatry, 60,  585–594 Hoff A.L., Riordan H., O’Donnell D.W., et al. (1992). Neuropsychological functioning of  first-episode schizophreniform patients. American Journal of Psychiatry, 149,  898–903. Hoffmann R.E., Buchsbaum M.S., Jensen R.V., et al. (1996). Dimensional complexity of  EEG waveforms in neuroleptic-free schizophrenic patients and normal control  subjects. Journal of Neuropsychiatry Clinical Neuroscience, 8, 436–441. Holzman P.S., Proctor L.R., Levy D.L., et al. (1974). Eye-tracking dysfunctions in  schizophrenic patients and their relatives. Archives of General Psychiatry, 31,  143–151.  82 Hort J., Grozek G., Komarek V., et al. (2000). Interstrain differences in cognitive  functions in  rats in relation to status epilepticus. Behavioural Brain Research, 112, 77-83. Ingvar D., & Franzen G. (1974). Distribution of cerebral activity in chronic  schizophrenia. Lancet, 2, 1484–1486. Jacobsen L.K., Hong W.L., Hommer D.W., et al. (1996). Smooth pursuit eye movements  in  childhood-onset schizophrenia: Comparison with attention-deficit hyperactivity  disorder and normal control subjects. Biological Psychiatry, 40, 1144–1154. Jay T.M., Glowinsky J., & Thierry A.M. (1989). Selectivity of the hippocampal projection to  the prelimbic area of the prefrontal cortex in the rat. Brain Research, 505, 337-340. Jay T.M., Rocher C., Hotte M., et al. (2004). Plasticity at hippocampal to prefrontal cortex  synapses is impaired by loss of dopamine and stress: Importance for psychiatry  diseases. Neurotoxicity Research, 6, 233-244. Jernigan T.L., Zisook S., Heaton R.K., et al. (1991). Magnetic resonance imaging  abnormalities in lenticular nuclei and cerebral cortex in schizophrenia. Archives of  General Psychiatry, 48, 881–890. Jeste D.V. & Lohr J.B. (1989). Hippocampal pathologic findings in schizophrenia. A  morphometric study. Archives of General Psychiatry, 48, 1019–1024. Johnson S.L.M., Wang L., Alpert K.I., et al. (2013). Hippocampal shape abnormalities of  patients with childhood-onset schizophrenia and their unaffected siblings. Journal  of the American Academy of Child and Adolescent Psychiatry, 52, 527-536.  Johnstone E., Frith C., & Kreel L. (1976). Cerebral ventricular size and cognitive impairment  in chronic schizophrenia. Lancet, 924-926. Johnstone E.C., Crow T.J., Frith C.D., et al. (1976). Cerebral ventricular size and  cognitive  impairment in chronic schizophrenia. The Lancet, 2, 924–926. Jones E.G. (1997). Cortical development and thalamic pathology in schizophrenia.  Schizophrenia Bulletin, 23, 483–501. Jones P., Rodgers B., Murray R., et al. (1994). Child developmental risk factors for adult  schizophrenia in the British 1946 birth cohort. Lancet, 344, 1398–1402. Joyal C.C., Laakso M.P., Tiihonen J., et al. (2002). A volumetric MRI study of the  entorhinal cortex in first episode neuroleptic-naive schizophrenia. Biological  Psychiatry, 51, 1005–1007. Juhana A. & Paavo Jr R. (1999). Blockade of NMDA receptors located at the  dorsomedial prefrontal cortex impairs spatial working memory in rats.  Neurophysiology, 10, 243-248.  83 Karson C.N., Coppola R., Morihisa J.M., et al. (1987). Computed  electroencephalographic  activity mapping in schizophrenia: The resting state  reconsidered. Archives of General  Psychiatry, 44, 514–517. Kawasaki Y., Maeda Y., Higashima M., et al. (1997).  Reduced auditory P300 amplitude,  medial temporal volume reduction and psychopathology in schizophrenia.   Schizophrenia Research, 26, 107–115. Kawasaki Y., Maeda Y., Suzuki M. et al (1993). SPECT analysis of regional cerebral  blood flow changes in patients with schizophrenia during the Wisconsin Card  Sorting Test. Schizophrenia Research, 10, 109–116. Kazemi M., Silva M., Li F., et al. (2004). Investigation of techniques to quantify in vivo  lesion volume based on comparison of water apparent diffusion coefficient (ADC)  maps with histology in focal cerebral ischemia of rats. Magnetic Resonance  Imaging, 22, 653–659.  Keefe R.S., Roitman S.E., Harvey P.D., et al. (1995). A pen-and-paper human analogue of a  monkey prefrontal cortex activation task: Spatial working memory in patients with  schizophrenia. Schizophrenia Research, 17, 25–33. Kolb B. & Gibb R. (1990). Anatomical correlates of behavioural change after neonatal  prefrontal lesions in rats. Progress in Brain Research, 85, 241-255. Kolb B. & Gibb R. (1993). Possible anatomical basis of recovery of function after  neonatal frontal lesions in rats. Behavioural Neuroscience, 107, 799-811. Kovelman J.A. & Scheibel A.B. (1984). A neurohistological correlate of schizophrenia.  Biological Psychiatry, 19, 1601–1621. Kremen W.S., Seidman L.J., Faraone S.V., et al. (1998). UQ decline during childhood and  adult psychotic symptoms in a community sample: a 19 year longitudinal  study.   American Journal of Psychiatry, 155, 672-679. Kuperberg G.R., Broome M.R., McGuire P.K., et al. (2003). Regionally localized  thinning of  the cerebral cortex in schizophrenia. Archives of General Psychiatry, 60, 878–888. Laplante F., Stevenson C.W., Gratton A., et al. (2004). Effects of neonatal ventral  hippocampal lesion in rats on stress-induced acetylcholine  release in the prefrontal  cortex.  Journal of Neurochemistry, 6, 1473-1482. Lawrie S., & Abukmeil S. (1998). Brain abnormality in schizophrenia. A systematic and  quantitative review of volumetric magnetic resonance imaging studies. British  Journal of Psychiatry, 172, 110–120. Lawrie S.M., Whalley H., Kestelman J.N., et al. (1999). Magnetic resonance imaging of  brain in people at high risk of developing schizophrenia. Lancet, 353, 30–33.   84 Lee H., Dvorak D., Kao H., et al. (2012). Early cognitive experience prevents adult  deficits in a neurodevelopmental schizophrenia model. Neuron, 75, 714–724. Lee J. & Park S. (2002). The role of stimulus-driven attention in spatial working memory  in  schizophrenia. Schizophrenia Research, 53, 131. Lee J. & Park S. (2005). Working memory impairments in schizophrenia: A meta- analysis.  Journal of Abnormal Psychology, 114, 599–611. Lee K. & Kornetsky C. (1998). Acute and chronic fluoxetine treatment decreases the  sensitivity of rats to rewarding brain stimulation. Pharmacology Biochemistry and  Behavior, 60, 539–544. Lewis D., Hashimoto T., & Volk D. (2005). Cortical inhibitory neurons and  schizophrenia. Nature Reviews Neuroscience, 6, 321–324. Lewis P.R. and Shute C.C.D. (1967). The cholinergic limbic system : Projections to  hippocampal formation, medial cortex, nuclei of the ascending cholinergic  reticula r formation and the subfornical organ and supraoptic crest. Brain, 90,  521–540. Lieberman J.A., Alvir J.M., Woerner M., et al. (1992). Prospective study of  psychobiology in first-episode schizophrenia at Hillside Hospital. Schizophrenia  Bulletins, 18, 351–371. Lieberman J.A., Perkins D., Belger A., et al. (2001). The early stages of schizophrenia:  Speculations on pathogenesis, pathophysiology, and therapeutic approaches.  Society of Biological Psychiatry, 50, 884–897. Lipska B.K. & Weinberger D.R. (1993). Delayed effects of neonatal hippocampal  damage on halperidol-induced catalepsy and apomorphine-induced stereotypic  behaviours in the rat. Developmental Brain Research, 75, 213–222. Lipska B.K. & Weinberger D.R. (1994). Subchronic treatment with haloperidol and  clozapine in rats with neonatal excitotoxic hippocampal damage.  Neuropsychopharmacology, 10, 199–205. Lipska B.K. & Weinberger D.R. (1998). Prefrontal cortical and hippocampal modulation  of  dopamine-mediated effects. Advances in Pharmacology, 42, 806–809. Lipska B.K. & Weinberger D.R. (2000). To model a psychiatric disorder in animals:  schizophrenia as a reality test. Neuropsychopharmacology, 23, 223–239. Lipska B.K. & Weinberger D.R. (2002). A neurodevelopmental model of schizophrenia:  Neonatal disconnection of the hippocampus. Neurotoxicity Research, 4, 5-6.  85 Lipska B.K., Al-Amin H.A., & Weinberger D.R. (1998). Excitotoxic lesions of the rat  medial prefrontal cortex: effects on abnormal behaviours associated with neonatal  hippocampal damage. Neuropsychopharmacology, 19, 451–464. Lipska B.K., Aultman J.M., Verma A., et al. (2002).  Neonatal damage of the ventral  hippocampus impairs working memory in the rat. Neuropsychopharmacology, 27,  47–53. Lipska B.K., Chrapusta S.J., Egan M.F., et al. (1995). Neonatal excitotoxic ventral  hippocampal damage alters dopamine response to mild repeated stress and to  chronic haloperidol. Synapse, 20, 125–130. Lipska B.K., Jaskiw G.E., & Weinberger D.R. (1993).  Postpubertal emergence of  hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic  hippocampal damage: A potential animal model of schizophrenia.  Neuropsychopharmacology, 9, 67–75. Lisman J.E., Coyle J.T., Green R.W., et al. (2008). Circuit-based framework for  understanding neurotransmitter and risk gene interactions in schizophrenia.  Trends in Neurosciences, 31, 234-242. Litman R.E., Torrey E.F., Hommer D.W., et al. (1997). A quantitative analysis of smooth  pursuit eye tracking in monozygotic twins discordant for schizophrenia. Archives  of  General Psychiatry, 54, 417–426. Luck S.J. (2008). Visual short-term memory. In: Luck SJ, Hollingworth A, eds. Visual  Memory. New York, NW: Oxford University Press, 43-85. MacDonald A.W., Carter C.S., Kerns J.G., et al. (2005). Specificity of prefrontal  dysfunction  and context processing deficits to schizophrenia in never-medicated patients with first- episode psychosis. American Journal of Psychiatry, 162, 475–484. Macedo C., Angst T., Guiberteau T., et al. (2010). Acoustic hypersensitivity in adult rats after  neonatal ventral hippocampal lesions. Behavioural Brain Research, 207, 161–168. Macedo C., Sandner M., Angst T., et al. (2008). Rewarded associative and instrumental  conditioning after neonatal ventral hippocampus lesions in rats. Brian Research,  1215, 190–199. Mahurin R.K., Velligan D.I., & Miller A.L. (1998). Executive-frontal lobe cognitive  dysfunction in schizophrenia: A symptom subtype analysis. Psychiatry Research,  79,  139–149. Malkova L., Lex C.K., Mishkin M., et al. (2001). MRI-Based evaluation of locus and  extent of neurotoxic lesions in monkeys. Hippocampus, 11, 361–370.  Manoach D. (2003). Prefrontal cortex dysfunction during working memory performance  in  schizophrenia: Reconciling discrepant findings. Schizophrenia Research, 60, 285–298.  86 Manoach D.S., Gollub R.L., Benson E.S., et al. (2000). Schizophrenic subjects show  aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during  working memory performance. Biological Psychiatry, 48, 99–109. Manoach D.S., Press D.Z., Thangaraj V., et al. (1999). Schizophrenic subjects activate  dorsolateral prefrontal cortex during a working memory task, as measured by  fMRI. Biological Psychiatry, 45, 1128–1137. Marcotte E., Pearson D., & Srivastava L. (2001). Animal models of schizophrenia: A  critical review. Journal of Psychiatry and Neuroscience, 26, 395-410. Marquis J., Goulet S., & Dore F. (2008). Dissociable onset of cognitive and motivational  dysfunctions following neonatal lesions of the ventral hippocampus in rats.  Behavioural Neuroscience, 122, 629-642. McAlonan G.M., Dawson G.R., Wilkinson L.O., et al. (1995). The effects of AMPA- induced lesions of the medial septum and vertical limb nucleus of the diagonal  band of Broca on spatial delayed non-matching to sample and spatial learning in the  water maze. European Journal of Neuroscience, 7, 1034–1049. McClure R.K. & Lieberman J.A. (2003). Neurodevelopmental and neurode- generative  hypotheses of schizophrenia: a review and critique. Current Opinions in Psychiatry,  16, S15–S28 McGrath J., Saha S., Welham J., et al. (2004). A systematic review of the incidence of  schizophrenia: The distribution of rates and the influence of sex, urbanicity,  migrant status, and methodology. BMC Medicine, 2, 13. McKinney M., Coyle J.T., & Hedreen J.C. (1983). Topographic analysis of the innervation of  the rat neocortex and hippocampus by the basal forebrain cholinergic system. Journal  of Computational Neurology, 217, 103–121. McKinney W.T. & Moran E.C. (1981). Animal models of schizophrenia. American  Journal of Psychiatry, 138, 478–483. Miller E.K. & Cohen J.D. (2001). An integrative theory of prefrontal cortex function.  Annual Review of Neuroscience, 24, 167–202. Miller M.H. and Orback J. (1972). Retention of spatial alternation following frontal lobe  resection in stump-tailed macaques. Neuropsychologia, 10, 291–298. Miyabe M., Mori S., van Zijl P.C.M., et al. (1996). Correlation of the average water  diffusion constant with cerebral blood flow and ischemic damage after transient  middle cerebral artery occlusion in cats. Journal of Cerebral Blood Flow  Metabolism, 16, 881–891.  87 Moser E., Moser M., Anderson P. (1993). Spatial learning impairment parallels the  magnitude of dorsal hippocampal lesions, but is hardly present following ventral  lesions. The Journal of Neuroscience, 13, 3916–3925. Murray C.J. & Lopez A.D. (1996). Global and regional descriptive epidemiology of   disability: Incidence, prevalence, health expectancies, and years lived with   disability. In: The global burden of disease: A comprehensive assessment of  mortality and disability from diseases, injuries, and risk factors in 1990 and  projected to 2020. Boston, MA: Harvard School of Public Health. Murray E.A. & Mishkin M. (1998). Object recognition and location memory in monkeys  with  excitotoxic lesions of the amygdala and hippocampus. Journal of Neuroscience, 18,  6568–6582. Murray R.M. & Lewis S.W. (1987). Is schizophrenia a neurodevelopmental disorder?  British Medical Journal, 295, 681–682. Naert A., Gantois I., Laeremans A., et al. (2013). Behavioural alterations relevant to  developmental brain disorders in mice with neonatally induced ventral  hippocampal lesions. Brain Research Bulletin, 94, 71-81. Narr K.L., Thompson P.M., Szeszko P., et al. (2004). Regional specificity of  hippocampal volume reductions in first-episode schizophrenia. Neuroimage, 21,  1563–1575. Narr K.L., Thompson P.M., Szeszko P., et al. (2004). Regional specificity of   hippocampal volume reductions in first-episode schizophrenia. Neuroimage,  21,1563-1575. Narr K.L., Van-Erp T.G., Cannon T.D., et al. (2002). A twin study of genetic  contributions to hippocampal morphology in schizophrenia. Neurobiology of  Disease, 11, 83–95. Nemanic S., Alvarado M.C., Price R.E., et al. (2002). Assessment of locus and extent of  neurotoxic lesions in monkeys using neuroimaging techniques : a replication.  Journal of Neuroscience Methods, 121, 199-209.  Nestor P.G., Kibicki R.J., Gurrera M., et al. (2004). Neuropsychological correlates of  diffusion tensor imaging in schizophrenia. Neuropsychology, 18, 629-637. Nesvaderani M., Matsumoto I., & Sivagnanasundaram S. (2009). Anterior hippocampusin  schizophrenia pathogenesis: Molecular evidence from a proteome study. Australian  and New Zealand Journal of Psychiatry, 43, 310–322. O’Donnell P., Greene J., Pabello N., et al. (1999). Modulation of cell firing in the nucleus  accumbens. Annuls of the New York Academy of Sciences, 877, 157–175.  88 O’Donnell P., Lewis B.L.,Weinberger D.R., et al. (2002).  Neonatal hippocampal damage  alters electrophysiological properties of prefrontal cortical neurons in adult rats.  Cerebral Cortex, 12, 975–982. Pantelis C., Velakoulis D., McGorry P.D., et al. (2003). Neuroanatomical abnormalities  before and after onset of psychosis: a cross-sectional and longitudinal MRI  comparison. Lancet, 361, 281–288.  Pantelis C., Velakoulis D., McGorry P.D., et al. (2003). Neuroanatomical abnormalities  before and after onset of psychosis: a cross-sectional and longitudinal MRI  comparison. Lancet, 361, 281–288. Park S., & Holzman P.S. (1992). Schizophrenics show spatial working memory deficits.  Archives in General Psychiatry, 49, 975–982. Park S., Holzman P.S. & Lenzenweger M.F. (1995). Individual differences in spatial  working memory in relation to schizotypy. Journal of Abnormal Psychology, 104,  355–363. Park S., Holzman P.S., & Goldman-Rakic P.S. (1995). Spatial working memory deficits in the  relatives of schizophrenic patients. Archives of General Psychiatry, 52, 821–828. Park S., Puschel J., Sauter B.H., et al. (1999). Spatial working memory deficits and  clinical symptoms in schizophrenia: a 4-months follow-up study. Biological  Psychiatry, 46, 392–400. Park S., Swisher T., & Knurek E. (2001). Affect facilitates prefrontal function in  schizophrenia: “What” modulates working memory for “where.” Schizophrenia  Research, 49, 118. Perlstein W.M., Carter C.S., Noll D.C., et al. (2001). Relation of prefrontal cortex  dysfunction  to working memory and symptoms in schizophrenia. American Journal of Psychiatry,  158, 1105–1113. Petrides M. (1995). Impairments on nonspatial self-ordered and externally ordered  working memory tasks after lesions of the mid-dorsal part of the lateral frontal  cortex in the monkey. The Journal of Neuroscience, 15, 359-375.  Petrides M. (1996). Specialized systems for the processing of mnemonic information  within the primate frontal cortex. Philosophical Transactions of the Royal Society,  351, 1455-1462.  Petrides M. (1998). Working memory and the mid-dorsolateral prefrontal cortex. Society  for  Neuroscience, Abstract, 24:18. Pfefferbaum A., Sullivan E.V., Adalsteinsson E., et al. (2004). Postmortem MR imaging of  formalin-fixed human brain. Neuroimage, 21, 1585-1595.  89 Porter C.M., Burk J.A., & Mair R.G. (2000). A comparison of the effects of hippocampal  or  prefrontal cortical lesions on three versions of delayed non-matching-to-sample  based on positional or spatial cues. Behavioural Brain Research, 109, 69-81. Ragozzino M.E.,Wilcox C., Raso M., et al. (1999). Involvement of rodent prefrontal  cortex subregions in strategy switching. Behavioural Neuroscience, 113, 32–41. Rajkowska G., Selemon L.D., & Goldman-Rakic P.S. (1998). Neuronal and glial somal size in  the prefrontal cortex: a postmortem morphometric study of schizophrenia and  Huntington disease. Archives of General Psychiatry, 55, 215–224. Rakic P.  (1988). Specification of cerebral cortical areas. Science, 241, 170-176. Rizzo L., Danion J.M., Van Der Linden M., Grange D., & Rohmer J.G. (1996).    Impairment of memory for spatial context in schizophrenia. Neuropsychology,   10, 376–384. Roberts G.W. (1990). Schizophrenia: the cellular biology of a functional psychosis.  Trends in Neuroscience, 13, 207–211. Rolls E.T., Loh M., Deco G., et al. (2008). Computational models of schizophrenia and  doamine modulation in the prefrontal cortex. Nature Reviews Neuroscience, 9, 696- 709. Rushworth M.F. and Behrens T.E. (2008). Choice, uncertainty and value in pre-frontal and  cingulate cortex. Nature Neuroscience, 11, 389–397. Sams-Dodd F., Lipska B.K., & Weinberger D.R. (1997). Neonatal lesions of the rat  ventral hippocampus result in hyperlocomotion and deficits in social behaviour in  adulthood. Psychopharmacology, 132, 303–310. Sanchez-Santed F., De Bruin J.P.C., Heinsbroek R.P.W., et al. (1997). Spatial delayed  alternation of rats in a T-maze : effects of neurotoxic lesions of the medial  prefrontal  cortex and of T-maze rotation. Behavioural Brain Research, 84, 73–79. Sandner G., Angst M., Guilberteau T., et al. (2010). MRI and X-ray scanning images of the  brain of 3-, 6-, and 9-month-old rats with bilateral neonatal ventral  hippocampus  lesions. Neuroimage, 53, 44-50. Sandner G., Meyer L., Angst T., et al. (2012). Neonatal ventral hippocampal lesions  modify pain perception and evoked potentials in rats. Behavioural Brain  Research,234, 167–174. Saunders R.C., Kolachana B.S., Bachevalier J., et al. (1998). Neonatal lesions of the  medial temporal lobe disrupt prefrontal cortical regulation of striatal dopamine.  Nature 393, 169–171.   90 Saykin A.J., Shtasei D.L., Gur R.E., et al. (1994). Neuropsychological deficits in  neuroleptic  naïve patients with first-episode schizophrenia. Archives of General Psychiatry, 51,  124–131. Schneider M. & Koch M. (2005). Behavioural and morphological alterations following  neonatal excitotoxic lesions of the medial prefrontal cortex in rats. Experimental   Neurology, 195, 185-198. Schrag M., Dickson A., Jiffry A., et al. (2010). The effects of formalin fixation on the levels  of brain transition metals in archived samples. Biometals, 23, 1123-1127 Schubert D., Martens G.J.M, & Kolk S.M. (2014). Molecular underpinnings of prefrontal  cortex development in rodents provide insights into the etiology of  neurodevelopmental disorders. Molecular Psychiatry, 1-15. Schubert D., Martens G.J.M., & Kolk S.M. (2014). Molecular underpinnings of prefrontal  cortex development in rodents provide insights into the etiology of  neurodevelopmental disorders. Molecular Psychiatry, 147, 1-15. Schwabe K., Enkel T., Klein S., et al. (2004). Effects of neonatal lesions on the medial  prefrontal cortex on adult rat behaviour. Behavioural Brain Research, 153, 21-34. Seeman P. (1987). Dopamine receptors and the dopamine hypothesis of schizophrenia.  Synapse, 1, 133-152. Shagass C., Amadeo M., & Overton D.A. (1974). Eye-tracking performance in psychiatric  patients. Biological Psychiatry, 9, 245–260. Shenton M.E., Dickey C.C., Frumin M., et al. (2001). A review of MRI findings in  schizophrenia. Schizophrenia Research, 49, 1–52. Silver H., Feldman P., Bilker W., et al. (2003). Working memory deficits as a core  neuropsychological dysfunction in schizophrenia. American Journal of Psychiatry,  160, 1809–1816. Sitskoorn M.M., Aleman A., Ebisch S.J., et al. (2004). Cognitive deficits in relatives of  patients with schizophrenia: A meta-analysis. Schizophrenia Research, 71, 285– 295. Squire L.R., Knowlton B., & Musen G. (1993). The structure and organization of  memory.  Annual Review of Psychology, 44, 453–495. Stevens A.A., Goldman-Rakic P.S., Gore J.C., et al. (1998). Cortical dysfunction in  schizophrenia during auditory word and tone working memory demonstrated by  functional magnetic resonance imaging. Archives of General Psychiatry, 55,  1097–1103. Stone M., Gabrieli J.D., Stebbins G.T., et al. (1998). Working and strategic memory  deficits in schizophrenia. Neuropsychology, 12, 278–288.  91 Strange B.A., Fletcher P.C., Henson R.N., et al. (1999). Segregating the functions of  human hippocampus. Proceedings of the National Academy of Science, USA, 96,  4034-4039. Suddath R.L., Christison G., Torrey E.F., et al. (1990). Anatomical abnormalities in the  brains of monozygotic twins discordant for schizophrenia. New England Journal  of  Medicine, 322, 789–794. Swanson L.W. (2004) Brain maps: structure of the rat brain. 3rd ed. New York, NY:  Elsevier. Szeszko P.R., Goldberg E., Gunduz-Bruce H., et al. (2003). Smaller anterior hippocampal  formation volume in antipsychotic-naive patients with first-episode schizophrenia.  American Journal of Psychiatry, 160, 2190–2197. Takano K., Carano R.A.D., Tatlisumak T., et al. (1998). Efficacy of intra-arterial and  intravenous prourokinase in an embolic stroke model evaluated by diffusion- perfusion magnetic resonance imaging. Neurology, 50, 870–875. Tauscher J., Fischer P., Neumeister A., et al. (1998). Low frontal electroencephalographic  coherence in neuroleptic-free schizophrenic patients. Biological Psychiatry, 44, 438– 447. Taylor S.F. (1996). Cerebral blood flow activation and functional lesions in  schizophrenia. Schizophrenia Research, 19, 129–140.  Tek C., Gold J., Blaxton T., et al. (2002). Visual perceptual and working memory  impairments in schizophrenia. Archives of General Psychiatry, 59, 146–153. Tseng K., Chambers R., & Lipska B. (2009). The neonatal ventral hippocampal lesion as  a  heuristic neurodevelopmental model of schizophrenia. Behavioural Brain  Research,  204, 295–305. Van Eden C.G. & Uylings H.B. (1985). Cytoarchitectonic development of the prefrontal  cortex in the rat.  Journal of Computational Neurology, 244, 349-359. Vanderschuren L.J., Schmidt E.D., De Vries T.J., et al. (1999). A single exposure to  amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and  neurochemical sensitization in rats. Journal of Neuroscience, 19, 9579–9586. Volk D.W., Austin M.C., Pierri J.N., et al. (2000). Decreased glutamic acid  decarboxylase67 mRNA expression in a subset of prefrontal cortical γ- aminobutyric acid neurons in subjects with schizophrenia. Archives of Geneneral  Psychiatry, 57, 237–245. Volz H.P., Gaser C., Hager F., et al. (1997). Brain activation during cognitive stimulation  with the Wisconsin Card Sorting Test: A functional MRI study on healthy  volunteers  and schizophrenics. Psychiatry Research, 75, 145–157.  92 Wehrl H.F., Bezrukov I., Wiehr S., et al. (2014). Assessment of murine brain tissue shrinkage  caused by different histological fixatives using magnetic resonance and computed  tomography imaging. Hitsology and Histopathology, 30, 1-13.  Weickert T.W., Goldberg T.E., Gold J.M., et al. (2000). Cognitive impairments in  patients with schizophrenia displaying preserved and compromised intellect.  Archives in General Psychiatry, 57, 907–913. Weinberger D.R. (1987). Implications of normal brain development for the pathogenesis  of  schizophrenia. Archives in General Psychiatry, 44, 660–669. Weinberger D.R. and Lipska B.K. (1995). Cortical maldevelopment, antipsychotic drugs  and  schizophrenia: a search for common ground. Schizophrenia Research, 16, 87–110. Weinberger D.R., Berman K.F. & Zec R.F. (1986). Physiologic dysfunction of dorsolateral  prefrontal cortex in schizophrenia: I. regional cerebral blood flow evidence. Archives  of General Psychiatry, 43, 114–124. Weinberger D.R., Berman K.F., & Illowsky B.P. (1988). Physiological dysfunction of   dorsolateral prefrontal cortex in schizophrenia: III. a new cohort and evidence for  a monoaminergic mechanism. Archives of General Psychiatry, 45, 609–615. Weinberger D.R., Berman K.F., Suddath R., et al. (1992). Evidence of dysfunction of a  prefrontal-limbic network in schizophrenia: A magnetic resonance imaging and  regional cerebral blood flow study of discordant monozygotic twins. American  Journal of Psychiatry, 149, 890–897. Weiss A.P., Dewitt I., Goff D., Ditman T., & Heckers, S. (2005). Anterior and posterior  hippocampal volumes in schizophrenia. Schizophrenia Research, 73, 103–112 Wexler B.E., Stevens A.A., Bowers A.A., et al. (1998). Word and tone working memory  deficits in schizophrenia. Archived in General Psychiatry, 55, 1093–1096. Wood G., Quirion R., & Srivastava L. (2003). Early environment contributes to  developmental disruption of mPFC after neonatal ventral hippocampal lesions in  rats.  Synapse, 50, 233-232. Wright I.C., Rabe-Hesketh S., Woodruff P.W.R., et al. (2000). Meta-analysis of regional  brain volumes in schizophrenia. American Journal of Psychiatry, 157, 16–25. Zaidel D.W., Esiri M.M., & Harrison P.J. (1997). Size, shape, and orientation of neurons  in  the left and right hippocampus: investigation of normal asymmetries and  alterations  in schizophrenia. American Journal of Psychiatry, 154, 812–818. Zhang W. & Luck S.J. (2009). Sudden death and gradual decay in visual working  memory.  Psychological Science, 20, 423-428.  93 Zipursky R.B., Lim K.O., Sullivan E.V., et al. (1992). Widespread cerebral gray matter  volume deficits in schizophrenia. Archives of General Psychiatry, 49, 195–205. Zola S.M., Squire L.R., Teng E., et al. (2000). Impaired recognition memory in monkeys   after damage limited to the hippocampal region. Journal of Neuroscience, 20,  451–463. Zola-Morgan S., Squire L.R., Rempel N.L., et al. (1992). Enduring memory impairment in  monkeys after ischemic damage to the hippocampus. The Journal of Neuroscience, 12,  2582–2596.   

Cite

Citation Scheme:

        

Citations by CSL (citeproc-js)

Usage Statistics

Share

Embed

Customize your widget with the following options, then copy and paste the code below into the HTML of your page to embed this item in your website.
                        
                            <div id="ubcOpenCollectionsWidgetDisplay">
                            <script id="ubcOpenCollectionsWidget"
                            src="{[{embed.src}]}"
                            data-item="{[{embed.item}]}"
                            data-collection="{[{embed.collection}]}"
                            data-metadata="{[{embed.showMetadata}]}"
                            data-width="{[{embed.width}]}"
                            async >
                            </script>
                            </div>
                        
                    
IIIF logo Our image viewer uses the IIIF 2.0 standard. To load this item in other compatible viewers, use this url:
https://iiif.library.ubc.ca/presentation/dsp.24.1-0167163/manifest

Comment

Related Items